16844790	153	Liggett SB	A polymorphism within a conserved beta(1)-adrenergic receptor motif alters cardiac function and beta-blocker response in human heart failure.	Proceedings of the National Academy of Sciences of the United States of America	2006	112
19234451	153	Dorsch S	Analysis of receptor oligomerization by FRAP microscopy.	Nature methods	2009	73
10573521	174	Theise ND	The canals of Hering and hepatic stem cells in humans.	Hepatology	1999	113
20066715	174	Carr BI	Therapeutic equivalence in survival for hepatic arterial chemoembolization and yttrium 90 microsphere treatments in unresectable hepatocellular carcinoma: a two-cohort study.	Cancer	2010	44
21621346	174	Yoon SM	Radiotherapy plus transarterial chemoembolization for hepatocellular carcinoma invading the portal vein: long-term patient outcomes.	International journal of radiation oncology, biology, physics	2012	60
11723063	177	Bierhaus A	Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB.	Diabetes	2001	155
12495433	177	Yonekura H	Novel splice variants of the receptor for advanced glycation end-products expressed in human vascular endothelial cells and pericytes, and their putative roles in diabetes-induced vascular injury.	The Biochemical journal	2003	128
16894049	177	Goldin A	Advanced glycation end products: sparking the development of diabetic vascular injury.	Circulation	2006	298
18089847	177	Hudson BI	Identification, classification, and expression of RAGE gene splice variants.	FASEB journal 	2008	79
10194466	183	Wallukat G	Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor.	The Journal of clinical investigation	1999	152
10699153	183	Kim S	Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases.	Pharmacological reviews	2000	150
12171785	183	Brasier AR	Vascular inflammation and the renin-angiotensin system.	Arteriosclerosis, thrombosis, and vascular biology	2002	86
15302780	183	de Zeeuw D	Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.	Circulation	2004	99
15718497	183	Jaffe IZ	Angiotensin II and aldosterone regulate gene transcription via functional mineralocortocoid receptors in human coronary artery smooth muscle cells.	Circulation research	2005	78
15919782	183	Wolf G	From the periphery of the glomerular capillary wall toward the center of disease: podocyte injury comes of age in diabetic nephropathy.	Diabetes	2005	124
16324688	183	Mehta JL	Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.	Cardiovascular research	2006	84
17452499	183	Wang M	Proinflammatory profile within the grossly normal aged human aortic wall.	Hypertension	2007	74
17588946	183	Martin MM	The human angiotensin II type 1 receptor +1166 A/C polymorphism attenuates microRNA-155 binding.	The Journal of biological chemistry	2007	88
18579813	183	Brooke BS	Angiotensin II blockade and aortic-root dilation in Marfan's syndrome.	The New England journal of medicine	2008	156
19050008	183	Sun Y	Myocardial repair/remodelling following infarction: roles of local factors.	Cardiovascular research	2009	57
19145003	183	Parving HH	Aliskiren Trial in Type 2 Diabetes Using Cardio-Renal Endpoints (ALTITUDE): rationale and study design.	Nephrology, dialysis, transplantation 	2009	51
20040868	183	Wang M	Arterial aging: a journey into subclinical arterial disease.	Current opinion in nephrology and hypertension	2010	47
20234356	183	Briet M	Aldosterone: effects on the kidney and cardiovascular system.	Nature reviews. Nephrology	2010	50
20393193	183	Malpas SC	Sympathetic nervous system overactivity and its role in the development of cardiovascular disease.	Physiological reviews	2010	117
20819950	183	de Cavanagh EM	Angiotensin II blockade: a strategy to slow ageing by protecting mitochondria?	Cardiovascular research	2011	35
21310411	183	Zhu N	Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration.	Atherosclerosis	2011	63
21670228	183	Goossens GH	Increased adipose tissue oxygen tension in obese compared with lean men is accompanied by insulin resistance, impaired adipose tissue capillarization, and inflammation.	Circulation	2011	53
22028412	183	Kim JA	Activation of mTOR/p70S6 kinase by ANG II inhibits insulin-stimulated endothelial nitric oxide synthase and vasodilation.	American journal of physiology. Endocrinology and metabolism	2012	34
22922412	183	McCurley A	Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors.	Nature medicine	2012	63
24776703	183	Jiang F	Angiotensin-converting enzyme 2 and angiotensin 1-7: novel therapeutic targets.	Nature reviews. Cardiology	2014	24
25421983	183	Li W	Intracerebroventricular infusion of the (Pro)renin receptor antagonist PRO20 attenuates deoxycorticosterone acetate-salt-induced hypertension.	Hypertension	2015	19
25767285	183	Hall JE	Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms.	Circulation research	2015	52
26116691	183	Lin X	Effects of Exercise Training on Cardiorespiratory Fitness and Biomarkers of Cardiometabolic Health: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.	Journal of the American Heart Association	2015	24
17255528	185	Bogdarina I	Epigenetic modification of the renin-angiotensin system in the fetal programming of hypertension.	Circulation research	2007	97
15504939	197	Reynolds JL	Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.	Journal of the American Society of Nephrology 	2004	140
25711438	197	Kapustin AN	Vascular smooth muscle cell calcification is mediated by regulated exosome secretion.	Circulation research	2015	36
10625301	207	Kim I	Angiopoietin-1 regulates endothelial cell survival through the phosphatidylinositol 3'-Kinase/Akt signal transduction pathway.	Circulation research	2000	128
10948069	207	van Nieuw Amerongen GP	Activation of RhoA by thrombin in endothelial hyperpermeability: role of Rho kinase and protein tyrosine kinases.	Circulation research	2000	99
11029403	207	Haynes MP	Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells.	Circulation research	2000	92
11673836	207	Tuder RM	Expression of angiogenesis-related molecules in plexiform lesions in severe pulmonary hypertension: evidence for a process of disordered angiogenesis.	The Journal of pathology	2001	102
11696579	207	Du XL	Hyperglycemia inhibits endothelial nitric oxide synthase activity by posttranslational modification at the Akt site.	The Journal of clinical investigation	2001	165
12039858	207	Humar R	Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling.	FASEB journal 	2002	84
12446767	207	Ming XF	Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells.	Molecular and cellular biology	2002	94
12810615	207	Hambrecht R	Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase.	Circulation	2003	131
14713953	207	Miyauchi H	Akt negatively regulates the in vitro lifespan of human endothelial cells via a p53/p21-dependent pathway.	The EMBO journal	2004	76
15319269	207	Wolfrum S	Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection.	Arteriosclerosis, thrombosis, and vascular biology	2004	98
15765134	207	Dorn GW 2nd	Protein kinase cascades in the regulation of cardiac hypertrophy.	The Journal of clinical investigation	2005	178
16428510	207	Qian DZ	Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.	Clinical cancer research 	2006	71
16942488	207	Jia G	Insulin-like growth factor-1 and TNF-alpha regulate autophagy through c-jun N-terminal kinase and Akt pathways in human atherosclerotic vascular smooth cells.	Immunology and cell biology	2006	83
17082639	207	Kim KS	A novel role of hypoxia-inducible factor in cobalt chloride- and hypoxia-mediated expression of IL-8 chemokine in human endothelial cells.	Journal of immunology	2006	62
17182864	207	Shiojima I	Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway.	Genes and development	2006	112
17204661	207	Minamino T	Vascular cell senescence: contribution to atherosclerosis.	Circulation research	2007	104
17627510	207	Maiese K	Mechanistic insights into diabetes mellitus and oxidative stress.	Current medicinal chemistry	2007	64
18701483	207	Schnell CR	Effects of the dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 on the tumor vasculature: implications for clinical imaging.	Cancer research	2008	60
19265662	207	Bleau AM	PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.	Cell stem cell	2009	219
19959541	207	Gurusamy N	Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway.	Cardiovascular research	2010	50
20110532	207	Chimenti I	Relative roles of direct regeneration versus paracrine effects of human cardiosphere-derived cells transplanted into infarcted mice.	Circulation research	2010	176
20360245	207	Meloni M	Nerve growth factor promotes cardiac repair following myocardial infarction.	Circulation research	2010	49
21464307	207	Xie X	IkappaB kinase epsilon and TANK-binding kinase 1 activate AKT by direct phosphorylation.	Proceedings of the National Academy of Sciences of the United States of America	2011	67
22586279	207	Chokshi A	Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure.	Circulation	2012	49
23589885	207	Kucharzewska P	Exosomes reflect the hypoxic status of glioma cells and mediate hypoxia-dependent activation of vascular cells during tumor development.	Proceedings of the National Academy of Sciences of the United States of America	2013	132
23737553	207	Lundby A	In vivo phosphoproteomics analysis reveals the cardiac targets of β-adrenergic receptor signaling.	Science signaling	2013	38
24009260	207	Parra V	Insulin stimulates mitochondrial fusion and function in cardiomyocytes via the Akt-mTOR-NFκB-Opa-1 signaling pathway.	Diabetes	2014	27
24285680	207	Uberti F	Vitamin D protects human endothelial cells from oxidative stress through the autophagic and survival pathways.	The Journal of clinical endocrinology and metabolism	2014	28
24813607	207	Naqvi N	A proliferative burst during preadolescence establishes the final cardiomyocyte number.	Cell	2014	58
25964336	207	Kuppusamy KT	Let-7 family of microRNA is required for maturation and adult-like metabolism in stem cell-derived cardiomyocytes.	Proceedings of the National Academy of Sciences of the United States of America	2015	28
11524400	284	Kamihata H	Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines.	Circulation	2001	144
19815705	284	Falcón BL	Contrasting actions of selective inhibitors of angiopoietin-1 and angiopoietin-2 on the normalization of tumor blood vessels.	The American journal of pathology	2009	58
21209923	284	Conroy AL	Endothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control study.	PloS one	2010	44
21742796	284	Goel S	Normalization of the vasculature for treatment of cancer and other diseases.	Physiological reviews	2011	282
22919072	284	Robson A	Uterine natural killer cells initiate spiral artery remodeling in human pregnancy.	FASEB journal 	2012	38
23136042	284	Huh D	A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice.	Science translational medicine	2012	76
23165704	284	Chen CW	Human pericytes for ischemic heart repair.	Stem cells	2013	45
23972477	284	Brudno Y	Enhancing microvascular formation and vessel maturation through temporal control over multiple pro-angiogenic and pro-maturation factors.	Biomaterials	2013	34
10974057	335	Navab M	Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.	Journal of lipid research	2000	92
11705484	335	Tounian P	Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study.	Lancet	2001	103
15314690	335	Zheng L	Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease.	The Journal of clinical investigation	2004	165
21226578	335	Khera AV	Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.	The New England journal of medicine	2011	401
23965489	335	Boekholdt SM	Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis.	Circulation	2013	30
24464187	335	Huang Y	An abundant dysfunctional apolipoprotein A1 in human atheroma.	Nature medicine	2014	46
17938300	338	Tabas I	Subendothelial lipoprotein retention as the initiating process in atherosclerosis: update and therapeutic implications.	Circulation	2007	236
21357823	338	Hermansson A	Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice.	Circulation	2011	39
23351925	338	Anderson TJ	2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult.	The Canadian journal of cardiology	2013	141
25082583	338	Boekholdt SM	Very low levels of atherogenic lipoproteins and the risk for cardiovascular events: a meta-analysis of statin trials.	Journal of the American College of Cardiology	2014	32
26361154	338	Capoulade R	Oxidized Phospholipids, Lipoprotein(a), and Progression of Calcific Aortic Valve Stenosis.	Journal of the American College of Cardiology	2015	25
16782234	348	Zipser BD	Microvascular injury and blood-brain barrier leakage in Alzheimer's disease.	Neurobiology of aging	2007	84
16820298	348	Hatters DM	Apolipoprotein E structure: insights into function.	Trends in biochemical sciences	2006	143
17332893	348	Vaisar T	Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL.	The Journal of clinical investigation	2007	238
17515542	348	Bowman GL	Blood-brain barrier impairment in Alzheimer disease: stability and functional significance.	Neurology	2007	55
18003940	348	Szekely CA	NSAID use and dementia risk in the Cardiovascular Health Study: role of APOE and NSAID type.	Neurology	2008	57
18349428	348	Calderón-Garcidueñas L	Long-term air pollution exposure is associated with neuroinflammation, an altered innate immune response, disruption of the blood-brain barrier, ultrafine particulate deposition, and accumulation of amyloid beta-42 and alpha-synuclein in children and young adults.	Toxicologic pathology	2008	103
18378884	348	Vernooij MW	Prevalence and risk factors of cerebral microbleeds: the Rotterdam Scan Study.	Neurology	2008	117
19319544	348	Bell RD	Neurovascular mechanisms and blood-brain barrier disorder in Alzheimer's disease.	Acta neuropathologica	2009	186
20155424	348	Grinberg LT	Vascular pathology in the aged human brain.	Acta neuropathologica	2010	61
20864661	348	Zhu YC	Severity of dilated Virchow-Robin spaces is associated with age, blood pressure, and MRI markers of small vessel disease: a population-based study.	Stroke	2010	48
26354483	348	Jaunmuktane Z	Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy.	Nature	2015	41
1608449	351	Haass C	Targeting of cell-surface beta-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments.	Nature	1992	138
18953056	351	Boche D	Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain.	Brain 	2008	80
19118806	351	Roher AE	Amyloid beta peptides in human plasma and tissues and their significance for Alzheimer's disease.	Alzheimer's and dementia 	2009	58
20101004	351	Hartz AM	Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease.	Molecular pharmacology	2010	63
22116809	351	Hartz AM	Amyloid-β contributes to blood-brain barrier leakage in transgenic human amyloid precursor protein mice and in humans with cerebral amyloid angiopathy.	Stroke	2012	36
17468766	387	Carè A	MicroRNA-133 controls cardiac hypertrophy.	Nature medicine	2007	477
17947237	387	Lagna G	Control of phenotypic plasticity of smooth muscle cells by bone morphogenetic protein signaling through the myocardin-related transcription factors.	The Journal of biological chemistry	2007	57
21622831	387	Satoh K	Rho-kinase: important new therapeutic target in cardiovascular diseases.	American journal of physiology. Heart and circulatory physiology	2011	58
22467316	387	Lacolley P	The vascular smooth muscle cell in arterial pathology: a cell that can take on multiple roles.	Cardiovascular research	2012	94
25857352	387	Mikelis CM	RhoA and ROCK mediate histamine-induced vascular leakage and anaphylactic shock.	Nature communications	2015	20
21486813	717	Sato K	The distribution of blood flow in the carotid and vertebral arteries during dynamic exercise in humans.	The Journal of physiology	2011	40
22495584	717	Willie CK	Regional brain blood flow in man during acute changes in arterial blood gases.	The Journal of physiology	2012	84
23615880	717	Wang W	Glycine metabolism in animals and humans: implications for nutrition and health.	Amino acids	2013	42
25190741	717	Verbree J	Assessment of middle cerebral artery diameter during hypocapnia and hypercapnia in humans using ultra-high-field MRI.	Journal of applied physiology	2014	31
15451780	947	Moreno PR	Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta: implications for plaque vulnerability.	Circulation	2004	93
15851598	947	Hofmann M	Monitoring of bone marrow cell homing into the infarcted human myocardium.	Circulation	2005	194
17562958	947	Losordo DW	Intramyocardial transplantation of autologous CD34+ stem cells for intractable angina: a phase I/IIa double-blind, randomized controlled trial.	Circulation	2007	118
20458011	947	Li B	Mobilized human hematopoietic stem/progenitor cells promote kidney repair after ischemia/reperfusion injury.	Circulation	2010	53
21167340	947	Quyyumi AA	CD34(+) cell infusion after ST elevation myocardial infarction is associated with improved perfusion and is dose dependent.	American heart journal	2011	36
21737787	947	Losordo DW	Intramyocardial, autologous CD34+ cell therapy for refractory angina.	Circulation research	2011	105
23065358	947	Vrtovec B	Effects of intracoronary CD34+ stem cell transplantation in nonischemic dilated cardiomyopathy patients: 5-year follow-up.	Circulation research	2013	43
24030420	947	Vrtovec B	Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy.	Circulation	2013	26
24271328	947	Neltner JH	Arteriolosclerosis that affects multiple brain regions is linked to hippocampal sclerosis of ageing.	Brain 	2014	28
4057091	966	Andersen P	Maximal perfusion of skeletal muscle in man.	The Journal of physiology	1985	208
10811742	966	Wilkinson IB	The influence of heart rate on augmentation index and central arterial pressure in humans.	The Journal of physiology	2000	114
19332353	966	Krum H	Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study.	Lancet	2009	258
20170948	966	Bakris GL	Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.	Lancet	2010	50
22206742	966	Jotwani V	Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.	American journal of kidney diseases 	2012	31
22614980	966	Jones LW	Cardiopulmonary function and age-related decline across the breast cancer survivorship continuum.	Journal of clinical oncology 	2012	47
23782649	966	Worthley SG	Safety and efficacy of a multi-electrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial.	European heart journal	2013	35
24902920	966	Ambrosius WT	The design and rationale of a multicenter clinical trial comparing two strategies for control of systolic blood pressure: the Systolic Blood Pressure Intervention Trial (SPRINT).	Clinical trials	2014	47
25393378	966	Naik RP	Association of sickle cell trait with chronic kidney disease and albuminuria in African Americans.	JAMA	2014	23
12062341	1000	Kostin S	Structural correlate of atrial fibrillation in human patients.	Cardiovascular research	2002	88
12547715	1000	Hirakawa S	Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells.	The American journal of pathology	2003	110
15851108	1000	Kaplan SR	Remodeling of myocyte gap junctions in arrhythmogenic right ventricular cardiomyopathy due to a deletion in plakoglobin (Naxos disease).	Heart rhythm	2004	78
18192323	1000	Yan HH	Blood-testis barrier dynamics are regulated by testosterone and cytokines via their differential effects on the kinetics of protein endocytosis and recycling in Sertoli cells.	FASEB journal 	2008	92
19279339	1000	Asimaki A	A new diagnostic test for arrhythmogenic right ventricular cardiomyopathy.	The New England journal of medicine	2009	93
20368523	1000	Campagnolo P	Human adult vena saphena contains perivascular progenitor cells endowed with clonogenic and proangiogenic potential.	Circulation	2010	67
22798562	1000	Ma D	Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.	European heart journal	2013	45
22912385	1000	Zhang J	Extracellular matrix promotes highly efficient cardiac differentiation of human pluripotent stem cells: the matrix sandwich method.	Circulation research	2012	122
26668317	1000	Noy PJ	TspanC8 Tetraspanins and A Disintegrin and Metalloprotease 10 (ADAM10) Interact via Their Extracellular Regions: EVIDENCE FOR DISTINCT BINDING MECHANISMS FOR DIFFERENT TspanC8 PROTEINS.	The Journal of biological chemistry	2016	10
9151786	1003	Zhou Y	Human cytotrophoblasts adopt a vascular phenotype as they differentiate. A strategy for successful endovascular invasion?	The Journal of clinical investigation	1997	162
9625748	1003	Esser S	Vascular endothelial growth factor induces VE-cadherin tyrosine phosphorylation in endothelial cells.	Journal of cell science	1998	157
10648408	1003	Peichev M	Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors.	Blood	2000	409
11157668	1003	Gill M	Vascular trauma induces rapid but transient mobilization of VEGFR2(+)AC133(+) endothelial precursor cells.	Circulation research	2001	132
11401930	1003	Shintani S	Mobilization of endothelial progenitor cells in patients with acute myocardial infarction.	Circulation	2001	156
11416160	1003	Hendrix MJ	Expression and functional significance of VE-cadherin in aggressive human melanoma cells: role in vasculogenic mimicry.	Proceedings of the National Academy of Sciences of the United States of America	2001	97
11490021	1003	Shaw SK	Real-time imaging of vascular endothelial-cadherin during leukocyte transmigration across endothelium.	Journal of immunology	2001	88
11827993	1003	Reyes M	Origin of endothelial progenitors in human postnatal bone marrow.	The Journal of clinical investigation	2002	179
12615796	1003	Rehman J	Peripheral blood "endothelial progenitor cells" are derived from monocyte/macrophages and secrete angiogenic growth factors.	Circulation	2003	318
14699017	1003	Hur J	Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis.	Arteriosclerosis, thrombosis, and vascular biology	2004	207
15345218	1003	Wang L	Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties.	Immunity	2004	107
15533859	1003	Wojakowski W	Mobilization of CD34/CXCR4+, CD34/CD117+, c-met+ stem cells, and mononuclear cells expressing early cardiac, muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction.	Circulation	2004	73
16115630	1003	Kooistra MR	Epac1 regulates integrity of endothelial cell junctions through VE-cadherin.	FEBS letters	2005	108
16141364	1003	Weksler BB	Blood-brain barrier-specific properties of a human adult brain endothelial cell line.	FASEB journal 	2005	269
16524930	1003	Zengin E	Vascular wall resident progenitor cells: a source for postnatal vasculogenesis.	Development	2006	104
17967785	1003	Traktuev DO	A population of multipotent CD34-positive adipose stromal cells share pericyte and mesenchymal surface markers, reside in a periendothelial location, and stabilize endothelial networks.	Circulation research	2008	205
18258663	1003	Förster C	Differential effects of hydrocortisone and TNFalpha on tight junction proteins in an in vitro model of the human blood-brain barrier.	The Journal of physiology	2008	59
18420943	1003	Schulz B	ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.	Circulation research	2008	58
18776942	1003	Murakami M	The FGF system has a key role in regulating vascular integrity.	The Journal of clinical investigation	2008	77
19658191	1003	Alvero AB	Stem-like ovarian cancer cells can serve as tumor vascular progenitors.	Stem cells	2009	56
19875721	1003	Nourse MB	VEGF induces differentiation of functional endothelium from human embryonic stem cells: implications for tissue engineering.	Arteriosclerosis, thrombosis, and vascular biology	2010	43
21876760	1003	Uosaki H	Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression.	PloS one	2011	77
22326223	1003	Tran KV	The vascular endothelium of the adipose tissue gives rise to both white and brown fat cells.	Cell metabolism	2012	81
22859612	1003	Yang Y	Lymphatic endothelial progenitors bud from the cardinal vein and intersomitic vessels in mammalian embryos.	Blood	2012	41
24992685	1003	Rochfort KD	Downregulation of blood-brain barrier phenotype by proinflammatory cytokines involves NADPH oxidase-dependent ROS generation: consequences for interendothelial adherens and tight junctions.	PloS one	2014	24
25956031	1003	Good RB	Endothelial to Mesenchymal Transition Contributes to Endothelial Dysfunction in Pulmonary Arterial Hypertension.	The American journal of pathology	2015	21
19942623	1268	Mukhopadhyay P	CB1 cannabinoid receptors promote oxidative stress and cell death in murine models of doxorubicin-induced cardiomyopathy and in human cardiomyocytes.	Cardiovascular research	2010	42
23551849	1268	Pacher P	Modulating the endocannabinoid system in human health and disease--successes and failures.	The FEBS journal	2013	62
3594774	1351	White HD	Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction.	Circulation	1987	221
6407019	1351	Edgell CJ	Permanent cell line expressing human factor VIII-related antigen established by hybridization.	Proceedings of the National Academy of Sciences of the United States of America	1983	311
11723017	1351	Heitzer T	Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease.	Circulation	2001	256
14688693	1351	Prasad SM	The Cox maze III procedure for atrial fibrillation: long-term efficacy in patients undergoing lone versus concomitant procedures.	The Journal of thoracic and cardiovascular surgery	2003	83
15547162	1351	Devereux RB	Prognostic significance of left ventricular mass change during treatment of hypertension.	JAMA	2004	104
15590763	1351	Foley RN	Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999.	Journal of the American Society of Nephrology 	2005	165
17928595	1351	Ford I	Long-term follow-up of the West of Scotland Coronary Prevention Study.	The New England journal of medicine	2007	71
21168019	1351	Damiano RJ Jr	The Cox maze IV procedure: predictors of late recurrence.	The Journal of thoracic and cardiovascular surgery	2011	37
24192549	1351	Maegele M	An update on the coagulopathy of trauma.	Shock	2014	20
9655393	1401	Staels B	Activation of human aortic smooth-muscle cells is inhibited by PPARalpha but not by PPARgamma activators.	Nature	1998	144
10231453	1401	Stenvinkel P	Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.	Kidney international	1999	158
11056086	1401	Pasceri V	Direct proinflammatory effect of C-reactive protein on human endothelial cells.	Circulation	2000	195
11673759	1401	Festa A	The relation of body fat mass and distribution to markers of chronic inflammation.	International journal of obesity and related metabolic disorders 	2001	107
11739301	1401	Chung MK	C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation.	Circulation	2001	196
11916939	1401	Stehouwer CD	Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes: progressive, interrelated, and independently associated with risk of death.	Diabetes	2002	94
12213876	1401	Ramsay JE	Maternal obesity is associated with dysregulation of metabolic, vascular, and inflammatory pathways.	The Journal of clinical endocrinology and metabolism	2002	103
12234944	1401	Venugopal SK	Demonstration that C-reactive protein decreases eNOS expression and bioactivity in human aortic endothelial cells.	Circulation	2002	99
12390945	1401	Hürlimann D	Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritis.	Circulation	2002	84
12551862	1401	Devaraj S	C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.	Circulation	2003	77
14557340	1401	Naghavi M	From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.	Circulation	2003	153
14996776	1401	Nissen SE	Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial.	JAMA	2004	214
15173060	1401	Landmesser U	Endothelial function: a critical determinant in atherosclerosis?	Circulation	2004	114
15197140	1401	Esposito K	Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus.	Circulation	2004	73
15234425	1401	Chrysohoou C	Adherence to the Mediterranean diet attenuates inflammation and coagulation process in healthy adults: The ATTICA Study.	Journal of the American College of Cardiology	2004	90
15262830	1401	Selvin E	Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000.	Circulation	2004	263
15447916	1401	Lopez-Garcia E	Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction.	The American journal of clinical nutrition	2004	141
15635110	1401	Nissen SE	Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease.	The New England journal of medicine	2005	137
15699278	1401	Desvarieux M	Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST).	Circulation	2005	111
16251237	1401	Kang DH	Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells.	Journal of the American Society of Nephrology 	2005	147
16251239	1401	Fried LF	Kidney function as a predictor of noncardiovascular mortality.	Journal of the American Society of Nephrology 	2005	78
16631001	1401	Klem I	Improved detection of coronary artery disease by stress perfusion cardiovascular magnetic resonance with the use of delayed enhancement infarction imaging.	Journal of the American College of Cardiology	2006	77
16642000	1401	Pepys MB	Targeting C-reactive protein for the treatment of cardiovascular disease.	Nature	2006	121
16784934	1401	Ferrario CM	Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.	The American journal of cardiology	2006	95
17164456	1401	Lange LA	Association of polymorphisms in the CRP gene with circulating C-reactive protein levels and cardiovascular events.	JAMA	2006	65
17192290	1401	Stewart FM	Longitudinal assessment of maternal endothelial function and markers of inflammation and placental function throughout pregnancy in lean and obese mothers.	The Journal of clinical endocrinology and metabolism	2007	59
17324119	1401	Savoia C	Vascular inflammation in hypertension and diabetes: molecular mechanisms and therapeutic interventions.	Clinical science	2007	72
17329698	1401	Tonetti MS	Treatment of periodontitis and endothelial function.	The New England journal of medicine	2007	166
17494805	1401	Yanbaeva DG	Systemic effects of smoking.	Chest	2007	152
17556718	1401	Drager LF	Effects of continuous positive airway pressure on early signs of atherosclerosis in obstructive sleep apnea.	American journal of respiratory and critical care medicine	2007	93
17576871	1401	Cao JJ	Association of carotid artery intima-media thickness, plaques, and C-reactive protein with future cardiovascular disease and all-cause mortality: the Cardiovascular Health Study.	Circulation	2007	65
17923467	1401	Ahn SG	Relationship of epicardial adipose tissue by echocardiography to coronary artery disease.	Heart	2008	56
18180395	1401	Wang TJ	Vitamin D deficiency and risk of cardiovascular disease.	Circulation	2008	497
18376000	1401	Kastelein JJ	Simvastatin with or without ezetimibe in familial hypercholesterolemia.	The New England journal of medicine	2008	172
18480203	1401	Zethelius B	Use of multiple biomarkers to improve the prediction of death from cardiovascular causes.	The New England journal of medicine	2008	179
19075102	1401	Liu PY	Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation.	Circulation	2009	53
19240794	1401	van Leeuwen WM	Sleep restriction increases the risk of developing cardiovascular diseases by augmenting proinflammatory responses through IL-17 and CRP.	PloS one	2009	82
19387353	1401	Triant VA	Association of C-reactive protein and HIV infection with acute myocardial infarction.	Journal of acquired immune deficiency syndromes	2009	99
19424218	1401	Mozaffarian D	Health effects of trans-fatty acids: experimental and observational evidence.	European journal of clinical nutrition	2009	60
19584191	1401	Nadeau KJ	Insulin resistance in adolescents with type 2 diabetes is associated with impaired exercise capacity.	The Journal of clinical endocrinology and metabolism	2009	46
19712036	1401	Ross AC	Relationship between inflammatory markers, endothelial activation markers, and carotid intima-media thickness in HIV-infected patients receiving antiretroviral therapy.	Clinical infectious diseases 	2009	75
19805772	1401	Helfand M	Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force.	Annals of internal medicine	2009	62
20181810	1401	Bakker GC	An antiinflammatory dietary mix modulates inflammation and oxidative and metabolic stress in overweight men: a nutrigenomics approach.	The American journal of clinical nutrition	2010	42
20394901	1401	Rogers IS	Feasibility of FDG imaging of the coronary arteries: comparison between acute coronary syndrome and stable angina.	JACC. Cardiovascular imaging	2010	52
20538833	1401	Goicoechea M	Effect of allopurinol in chronic kidney disease progression and cardiovascular risk.	Clinical journal of the American Society of Nephrology 	2010	124
21200002	1401	Anderson TJ	Microvascular function predicts cardiovascular events in primary prevention: long-term results from the Firefighters and Their Endothelium (FATE) study.	Circulation	2011	55
21542910	1401	Carson V	Volume, patterns, and types of sedentary behavior and cardio-metabolic health in children and adolescents: a cross-sectional study.	BMC public health	2011	44
21616287	1401	Fallah-Rad N	The utility of cardiac biomarkers, tissue velocity and strain imaging, and cardiac magnetic resonance imaging in predicting early left ventricular dysfunction in patients with human epidermal growth factor receptor II-positive breast cancer treated with adjuvant trastuzumab therapy.	Journal of the American College of Cardiology	2011	62
21718915	1401	Al Mheid I	Vitamin D status is associated with arterial stiffness and vascular dysfunction in healthy humans.	Journal of the American College of Cardiology	2011	62
21835901	1401	Colish J	Obstructive sleep apnea: effects of continuous positive airway pressure on cardiac remodeling as assessed by cardiac biomarkers, echocardiography, and cardiac MRI.	Chest	2012	32
21856482	1401	Blaha MJ	Associations between C-reactive protein, coronary artery calcium, and cardiovascular events: implications for the JUPITER population from MESA, a population-based cohort study.	Lancet	2011	59
22237295	1401	Bind MA	Air pollution and markers of coagulation, inflammation, and endothelial function: associations and epigene-environment interactions in an elderly cohort.	Epidemiology	2012	67
22431676	1401	Kavousi M	Evaluation of newer risk markers for coronary heart disease risk classification: a cohort study.	Annals of internal medicine	2012	57
22492856	1401	Parrinello CM	Cytomegalovirus immunoglobulin G antibody is associated with subclinical carotid artery disease among HIV-infected women.	The Journal of infectious diseases	2012	41
22820791	1401	Subramanian S	Arterial inflammation in patients with HIV.	JAMA	2012	122
22910756	1401	Yeboah J	Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals.	JAMA	2012	143
24154724	1401	Rook GA	Regulation of the immune system by biodiversity from the natural environment: an ecosystem service essential to health.	Proceedings of the National Academy of Sciences of the United States of America	2013	38
24284436	1401	Ley SH	Associations between red meat intake and biomarkers of inflammation and glucose metabolism in women.	The American journal of clinical nutrition	2014	22
24864079	1401	Ridker PM	Anti-inflammatory therapies for cardiovascular disease.	European heart journal	2014	40
25710246	1401	Hajat A	Long-term exposure to air pollution and markers of inflammation, coagulation, and endothelial activation: a repeat-measures analysis in the Multi-Ethnic Study of Atherosclerosis (MESA).	Epidemiology	2015	21
25835438	1401	Puri R	Impact of statins on serial coronary calcification during atheroma progression and regression.	Journal of the American College of Cardiology	2015	25
25965853	1401	Dopico XC	Widespread seasonal gene expression reveals annual differences in human immunity and physiology.	Nature communications	2015	40
26117398	1401	Vlachopoulos C	The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society.	Atherosclerosis	2015	31
9393975	1432	Rousseau S	p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.	Oncogene	1997	155
10604986	1432	Kol A	Cutting edge: heat shock protein (HSP) 60 activates the innate immune response: CD14 is an essential receptor for HSP60 activation of mononuclear cells.	Journal of immunology	2000	102
12639843	1432	Birukov KG	Magnitude-dependent regulation of pulmonary endothelial cell barrier function by cyclic stretch.	American journal of physiology. Lung cellular and molecular physiology	2003	86
16198162	1432	Kaminska B	MAPK signalling pathways as molecular targets for anti-inflammatory therapy--from molecular mechanisms to therapeutic benefits.	Biochimica et biophysica acta	2005	142
16385087	1432	Isoda K	Metformin inhibits proinflammatory responses and nuclear factor-kappaB in human vascular wall cells.	Arteriosclerosis, thrombosis, and vascular biology	2006	72
17032753	1432	Engel FB	FGF1/p38 MAP kinase inhibitor therapy induces cardiomyocyte mitosis, reduces scarring, and rescues function after myocardial infarction.	Proceedings of the National Academy of Sciences of the United States of America	2006	88
17481747	1432	Cuenda A	p38 MAP-kinases pathway regulation, function and role in human diseases.	Biochimica et biophysica acta	2007	249
18021257	1432	Graichen R	Enhanced cardiomyogenesis of human embryonic stem cells by a small molecular inhibitor of p38 MAPK.	Differentiation; research in biological diversity	2008	50
19074475	1432	Steiner MK	Interleukin-6 overexpression induces pulmonary hypertension.	Circulation research	2009	120
19236889	1432	Siu ER	Cadmium-induced testicular injury.	Toxicology and applied pharmacology	2009	54
20110572	1432	Schwartz EA	Nutrient modification of the innate immune response: a novel mechanism by which saturated fatty acids greatly amplify monocyte inflammation.	Arteriosclerosis, thrombosis, and vascular biology	2010	42
20150510	1432	Shi J	Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway.	Proceedings of the National Academy of Sciences of the United States of America	2010	51
20643109	1432	Paine A	Signaling to heme oxygenase-1 and its anti-inflammatory therapeutic potential.	Biochemical pharmacology	2010	135
21047517	1432	Földes G	Modulation of human embryonic stem cell-derived cardiomyocyte growth: a testbed for studying human cardiac hypertrophy?	Journal of molecular and cellular cardiology	2011	36
21144973	1432	Rajesh M	Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.	Journal of the American College of Cardiology	2010	56
21691084	1432	Molinari C	1α,25-dihydroxycholecalciferol induces nitric oxide production in cultured endothelial cells.	Cellular physiology and biochemistry 	2011	37
22254000	1432	Vauzour D	Polyphenols and human health: prevention of disease and mechanisms of action.	Nutrients	2010	61
17225955	1464	Virgintino D	An intimate interplay between precocious, migrating pericytes and endothelial cells governs human fetal brain angiogenesis.	Angiogenesis	2007	57
17293855	1464	Dellavalle A	Pericytes of human skeletal muscle are myogenic precursors distinct from satellite cells.	Nature cell biology	2007	243
18295964	1464	Covas DT	Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts.	Experimental hematology	2008	135
18786417	1464	Crisan M	A perivascular origin for mesenchymal stem cells in multiple human organs.	Cell stem cell	2008	880
19796239	1464	Crisan M	Perivascular multipotent progenitor cells in human organs.	Annals of the New York Academy of Sciences	2009	51
22882758	1464	Crisan M	Perivascular cells for regenerative medicine.	Journal of cellular and molecular medicine	2012	40
25336400	1464	Chen WC	Human myocardial pericytes: multipotent mesodermal precursors exhibiting cardiac specificity.	Stem cells	2015	21
9651244	1482	Schott JJ	Congenital heart disease caused by mutations in the transcription factor NKX2-5.	Science	1998	221
10587520	1482	Benson DW	Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways.	The Journal of clinical investigation	1999	106
11431700	1482	Hiroi Y	Tbx5 associates with Nkx2-5 and synergistically promotes cardiomyocyte differentiation.	Nature genetics	2001	115
12242268	1482	Xu C	Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells.	Circulation research	2002	162
15109497	1482	Pashmforoush M	Nkx2-5 pathways and congenital heart disease; loss of ventricular myocyte lineage specification leads to progressive cardiomyopathy and complete heart block.	Cell	2004	103
20723802	1482	Behfar A	Guided cardiopoiesis enhances therapeutic benefit of bone marrow human mesenchymal stem cells in chronic myocardial infarction.	Journal of the American College of Cardiology	2010	62
20838637	1482	Zhang Y	Dedifferentiation and proliferation of mammalian cardiomyocytes.	PloS one	2010	60
21242485	1482	Mishra R	Characterization and functionality of cardiac progenitor cells in congenital heart patients.	Circulation	2011	67
22965990	1482	Kawamura M	Feasibility, safety, and therapeutic efficacy of human induced pluripotent stem cell-derived cardiomyocyte sheets in a porcine ischemic cardiomyopathy model.	Circulation	2012	83
23463007	1482	Nakano H	Haemogenic endocardium contributes to transient definitive haematopoiesis.	Nature communications	2013	40
24255110	1482	Thavandiran N	Design and formulation of functional pluripotent stem cell-derived cardiac microtissues.	Proceedings of the National Academy of Sciences of the United States of America	2013	59
25082575	1482	Sanchez-Freire V	Effect of human donor cell source on differentiation and function of cardiac induced pluripotent stem cells.	Journal of the American College of Cardiology	2014	23
26875865	1482	Luna-Zurita L	Complex Interdependence Regulates Heterotypic Transcription Factor Distribution and Coordinates Cardiogenesis.	Cell	2016	12
17376414	1490	Ruiz-Ortega M	TGF-beta signaling in vascular fibrosis.	Cardiovascular research	2007	125
19096030	1490	Duisters RF	miR-133 and miR-30 regulate connective tissue growth factor: implications for a role of microRNAs in myocardial matrix remodeling.	Circulation research	2009	227
16823493	1499	Garcia-Gras E	Suppression of canonical Wnt/beta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.	The Journal of clinical investigation	2006	135
17576928	1499	Kwon C	Canonical Wnt signaling is a positive regulator of mammalian cardiac progenitors.	Proceedings of the National Academy of Sciences of the United States of America	2007	96
18371348	1499	Qyang Y	The renewal and differentiation of Isl1+ cardiovascular progenitors are controlled by a Wnt/beta-catenin pathway.	Cell stem cell	2007	117
21108734	1499	Marchand A	The Wnt/beta-catenin pathway is activated during advanced arterial aging in humans.	Aging cell	2011	35
21821917	1499	Alastalo TP	Disruption of PPARγ/β-catenin-mediated regulation of apelin impairs BMP-induced mouse and human pulmonary arterial EC survival.	The Journal of clinical investigation	2011	53
22645348	1499	Lian X	Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling.	Proceedings of the National Academy of Sciences of the United States of America	2012	274
22729031	1499	Lippmann ES	Derivation of blood-brain barrier endothelial cells from human pluripotent stem cells.	Nature biotechnology	2012	68
23257984	1499	Lian X	Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt/β-catenin signaling under fully defined conditions.	Nature protocols	2013	167
23354045	1499	Kim C	Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs.	Nature	2013	98
24936790	1499	Cecchelli R	A stable and reproducible human blood-brain barrier model derived from hematopoietic stem cells.	PloS one	2014	22
25848746	1499	D'Uva G	ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.	Nature cell biology	2015	56
11940543	1535	Guzik TJ	Mechanisms of increased vascular superoxide production in human diabetes mellitus: role of NAD(P)H oxidase and endothelial nitric oxide synthase.	Circulation	2002	189
14578299	1535	Quagliaro L	Intermittent high glucose enhances apoptosis related to oxidative stress in human umbilical vein endothelial cells: the role of protein kinase C and NAD(P)H-oxidase activation.	Diabetes	2003	124
15322091	1535	Ambasta RK	Direct interaction of the novel Nox proteins with p22phox is required for the formation of a functionally active NADPH oxidase.	The Journal of biological chemistry	2004	159
16123335	1535	Kim YM	A myocardial Nox2 containing NAD(P)H oxidase contributes to oxidative stress in human atrial fibrillation.	Circulation research	2005	76
16293794	1535	Guzik TJ	Coronary artery superoxide production and nox isoform expression in human coronary artery disease.	Arteriosclerosis, thrombosis, and vascular biology	2006	68
15706079	1536	Van Buul JD	Expression and localization of NOX2 and NOX4 in primary human endothelial cells.	Antioxidants and redox signaling	2005	102
18783311	1536	Pendyala S	Role of Nox4 and Nox2 in hyperoxia-induced reactive oxygen species generation and migration of human lung endothelial cells.	Antioxidants and redox signaling	2009	67
20981034	1536	Touyz RM	Reactive oxygen species and vascular biology: implications in human hypertension.	Hypertension research 	2011	81
22405985	1536	Schramm A	Targeting NADPH oxidases in vascular pharmacology.	Vascular pharmacology	2012	42
22445098	1536	Montezano AC	Molecular mechanisms of hypertension--reactive oxygen species and antioxidants: a basic science update for the clinician.	The Canadian journal of cardiology	2012	43
22713144	1536	Montezano AC	Oxidative stress, Noxs, and hypertension: experimental evidence and clinical controversies.	Annals of medicine	2012	41
23600794	1536	Montezano AC	Reactive oxygen species, vascular Noxs, and hypertension: focus on translational and clinical research.	Antioxidants and redox signaling	2014	29
24180474	1536	Konior A	NADPH oxidases in vascular pathology.	Antioxidants and redox signaling	2014	39
25066192	1536	Drummond GR	Endothelial NADPH oxidases: which NOX to target in vascular disease?	Trends in endocrinology and metabolism	2014	35
25564678	1536	Sullivan MN	Localized TRPA1 channel Ca2+ signals stimulated by reactive oxygen species promote cerebral artery dilation.	Science signaling	2015	19
25645978	1536	Cocks M	Sprint interval and moderate-intensity continuous training have equal benefits on aerobic capacity, insulin sensitivity, muscle capillarisation and endothelial eNOS/NAD(P)Hoxidase protein ratio in obese men.	The Journal of physiology	2016	12
22528806	1628	Chun RF	New perspectives on the vitamin D binding protein.	Cell biochemistry and function	2012	37
9450756	1636	Eiserich JP	Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils.	Nature	1998	203
10716457	1636	Cohn JN	Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.	Journal of the American College of Cardiology	2000	303
10969042	1636	Donoghue M	A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9.	Circulation research	2000	242
11181474	1636	Guerin AP	Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure.	Circulation	2001	116
11566918	1636	London GM	Arterial wave reflections and survival in end-stage renal failure.	Hypertension	2001	109
12020339	1636	Beckman JA	Diabetes and atherosclerosis: epidemiology, pathophysiology, and management.	JAMA	2002	339
12584366	1636	Wing LM	A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderly.	The New England journal of medicine	2003	95
12600911	1636	Hein S	Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms.	Circulation	2003	157
15531767	1636	Braunwald E	Angiotensin-converting-enzyme inhibition in stable coronary artery disease.	The New England journal of medicine	2004	117
16760444	1636	Cooper WO	Major congenital malformations after first-trimester exposure to ACE inhibitors.	The New England journal of medicine	2006	115
17336879	1636	Everett TH 4th	Atrial fibrosis and the mechanisms of atrial fibrillation.	Heart rhythm	2007	56
17970613	1636	Atlas SA	The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition.	Journal of managed care pharmacy 	2007	67
18757085	1636	Telmisartan Randomised AssessmeNt Study in ACE iNtolerant subjects with cardiovascular Disease (TRANSCEND) Investigators.	Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.	Lancet	2008	132
19052124	1636	Jamerson K	Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.	The New England journal of medicine	2008	232
19597068	1636	Sink KM	Angiotensin-converting enzyme inhibitors and cognitive decline in older adults with hypertension: results from the Cardiovascular Health Study.	Archives of internal medicine	2009	48
20440277	1636	Ruggenenti P	The RAAS in the pathogenesis and treatment of diabetic nephropathy.	Nature reviews. Nephrology	2010	43
20486275	1636	Yu MA	Oxidative stress with an activation of the renin-angiotensin system in human vascular endothelial cells as a novel mechanism of uric acid-induced endothelial dysfunction.	Journal of hypertension	2010	65
20625111	1636	Hsu DT	Enalapril in infants with single ventricle: results of a multicenter randomized trial.	Circulation	2010	43
22124756	1636	Agarwal D	Chronic exercise modulates RAS components and improves balance between pro- and anti-inflammatory cytokines in the brain of SHR.	Basic research in cardiology	2011	36
22511654	1636	van Vark LC	Angiotensin-converting enzyme inhibitors reduce mortality in hypertension: a meta-analysis of randomized clinical trials of renin-angiotensin-aldosterone system inhibitors involving 158,998 patients.	European heart journal	2012	51
23100218	1636	Ruggenenti P	Mechanisms and treatment of CKD.	Journal of the American Society of Nephrology 	2012	34
24206457	1636	Fried LF	Combined angiotensin inhibition for the treatment of diabetic nephropathy.	The New England journal of medicine	2013	107
25399731	1636	Torres VE	Angiotensin blockade in late autosomal dominant polycystic kidney disease.	The New England journal of medicine	2014	25
25767283	1636	Te Riet L	Hypertension: renin-angiotensin-aldosterone system alterations.	Circulation research	2015	42
9438410	1674	L'Heureux N	A completely biological tissue-engineered human blood vessel.	FASEB journal 	1998	172
11772882	1674	Toma C	Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart.	Circulation	2002	395
9563954	1756	Olson TM	Actin mutations in dilated cardiomyopathy, a heritable form of heart failure.	Science	1998	110
12589117	1756	Finsterer J	The heart in human dystrophinopathies.	Cardiology	2003	92
16025101	1756	Yasuda S	Dystrophic heart failure blocked by membrane sealant poloxamer.	Nature	2005	87
17440445	1756	Townsend D	Systemic administration of micro-dystrophin restores cardiac geometry and prevents dobutamine-induced cardiac pump failure.	Molecular therapy 	2007	60
24434629	1756	Guan X	Dystrophin-deficient cardiomyocytes derived from human urine: new biologic reagents for drug discovery.	Stem cell research	2014	23
25791035	1756	Lin B	Modeling and study of the mechanism of dilated cardiomyopathy using induced pluripotent stem cells derived from individuals with Duchenne muscular dystrophy.	Disease models and mechanisms	2015	19
21593202	1803	Lamers D	Dipeptidyl peptidase 4 is a novel adipokine potentially linking obesity to the metabolic syndrome.	Diabetes	2011	94
21734003	1803	Drucker DJ	The safety of incretin-based therapies--review of the scientific evidence.	The Journal of clinical endocrinology and metabolism	2011	40
22323472	1803	Ussher JR	Cardiovascular biology of the incretin system.	Endocrine reviews	2012	96
22748821	1803	Gallwitz B	2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial.	Lancet	2012	69
23296071	1803	Scheen AJ	Cardiovascular effects of gliptins.	Nature reviews. Cardiology	2013	27
23386232	1803	Matsubara J	Dipeptidyl peptidase-4 inhibitor, sitagliptin, improves endothelial dysfunction in association with its anti-inflammatory effects in patients with coronary artery disease and uncontrolled diabetes.	Circulation journal 	2013	33
23525426	1803	Ayaori M	Dipeptidyl peptidase-4 inhibitors attenuate endothelial function as evaluated by flow-mediated vasodilatation in type 2 diabetic patients.	Journal of the American Heart Association	2013	31
23653460	1803	Aroor AR	Dipeptidylpeptidase inhibition is associated with improvement in blood pressure and diastolic function in insulin-resistant male Zucker obese rats.	Endocrinology	2013	38
23894014	1803	dos Santos L	Circulating dipeptidyl peptidase IV activity correlates with cardiac dysfunction in human and experimental heart failure.	Circulation. Heart failure	2013	26
23932846	1803	Aroor AR	Maladaptive immune and inflammatory pathways lead to cardiovascular insulin resistance.	Metabolism	2013	41
24855202	1803	Ussher JR	Cardiovascular actions of incretin-based therapies.	Circulation research	2014	40
25074318	1803	Nakamura K	DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study.	Cardiovascular diabetology	2014	23
26489970	1803	Nauck M	Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors.	Diabetes, obesity and metabolism	2016	14
26628419	1803	Mita T	Alogliptin, a Dipeptidyl Peptidase 4 Inhibitor, Prevents the Progression of Carotid Atherosclerosis in Patients With Type 2 Diabetes: The Study of Preventive Effects of Alogliptin on Diabetic Atherosclerosis (SPEAD-A).	Diabetes care	2016	14
26822324	1803	Mita T	Sitagliptin Attenuates the Progression of Carotid Intima-Media Thickening in Insulin-Treated Patients With Type 2 Diabetes: The Sitagliptin Preventive Study of Intima-Media Thickness Evaluation (SPIKE): A Randomized Controlled Trial.	Diabetes care	2016	14
2649896	1906	Inoue A	The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes.	Proceedings of the National Academy of Sciences of the United States of America	1989	247
8497283	1906	Giaid A	Expression of endothelin-1 in the lungs of patients with pulmonary hypertension.	The New England journal of medicine	1993	200
15194177	1906	Barst RJ	Diagnosis and differential assessment of pulmonary arterial hypertension.	Journal of the American College of Cardiology	2004	114
16258029	1906	Larsen BT	Epoxyeicosatrienoic and dihydroxyeicosatrienoic acids dilate human coronary arterioles via BK(Ca) channels: implications for soluble epoxide hydrolase inhibition.	American journal of physiology. Heart and circulatory physiology	2006	66
16618833	1906	Kim JA	Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms.	Circulation	2006	269
17179929	1906	Rask-Madsen C	Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes.	Nature clinical practice. Endocrinology and metabolism	2007	104
17242275	1906	Silver AE	Overweight and obese humans demonstrate increased vascular endothelial NAD(P)H oxidase-p47(phox) expression and evidence of endothelial oxidative stress.	Circulation	2007	56
18256324	1906	Au P	Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature.	Blood	2008	138
18261470	1906	Wood KC	Sickle cell disease vasculopathy: a state of nitric oxide resistance.	Free radical biology and medicine	2008	53
18629317	1906	Peretz A	Diesel exhaust inhalation elicits acute vasoconstriction in vivo.	Environmental health perspectives	2008	59
19149564	1906	Potenza MA	Endothelial dysfunction in diabetes: from mechanisms to therapeutic targets.	Current medicinal chemistry	2009	61
19465546	1906	Donato AJ	Vascular endothelial dysfunction with aging: endothelin-1 and endothelial nitric oxide synthase.	American journal of physiology. Heart and circulatory physiology	2009	73
19903865	1906	Chen S	Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells.	American journal of physiology. Endocrinology and metabolism	2010	49
21244363	1906	Seals DR	Aging and vascular endothelial function in humans.	Clinical science	2011	117
21683931	1906	D'haeseleer M	Vascular aspects of multiple sclerosis.	The Lancet. Neurology	2011	37
23649149	1906	Kong P	The pathogenesis of cardiac fibrosis.	Cellular and molecular life sciences 	2014	93
23832699	1906	Ivashchenko CY	Human-induced pluripotent stem cell-derived cardiomyocytes exhibit temporal changes in phenotype.	American journal of physiology. Heart and circulatory physiology	2013	29
24951764	1906	Paulin R	The metabolic theory of pulmonary arterial hypertension.	Circulation research	2014	33
26711459	1906	Love S	Cerebrovascular disease in ageing and Alzheimer's disease.	Acta neuropathologica	2016	16
26956245	1906	Davenport AP	Endothelin.	Pharmacological reviews	2016	22
19109410	1956	Graner MW	Proteomic and immunologic analyses of brain tumor exosomes.	FASEB journal 	2009	101
19421193	1956	Bos PD	Genes that mediate breast cancer metastasis to the brain.	Nature	2009	433
20018733	1956	Chan G	Activation of EGFR on monocytes is required for human cytomegalovirus entry and mediates cellular motility.	Proceedings of the National Academy of Sciences of the United States of America	2009	56
20671236	1956	Zhu WZ	Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells.	Circulation research	2010	59
21610077	1956	Kinney SM	Tissue-specific distribution and dynamic changes of 5-hydroxymethylcytosine in mammalian genomes.	The Journal of biological chemistry	2011	46
22898678	1956	Leboulleux S	Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.	The Lancet. Oncology	2012	56
25137181	1956	Marchetti A	Assessment of EGFR mutations in circulating tumor cell preparations from NSCLC patients by next generation sequencing: toward a real-time liquid biopsy for treatment.	PloS one	2014	33
26206882	1956	Uchida J	Diagnostic Accuracy of Noninvasive Genotyping of EGFR in Lung Cancer Patients by Deep Sequencing of Plasma Cell-Free DNA.	Clinical chemistry	2015	25
26898616	1956	Tan CS	Next-generation epidermal growth factor receptor tyrosine kinase inhibitors in epidermal growth factor receptor -mutant non-small cell lung cancer.	Lung cancer	2016	17
17601538	2006	O'Rourke MF	Mechanical factors in arterial aging: a clinical perspective.	Journal of the American College of Cardiology	2007	149
21994960	2006	Spencer M	Adipose tissue extracellular matrix and vascular abnormalities in obesity and insulin resistance.	The Journal of clinical endocrinology and metabolism	2011	48
22729285	2006	Wu W	Fast-degrading elastomer enables rapid remodeling of a cell-free synthetic graft into a neoartery.	Nature medicine	2012	53
23536538	2006	Tsamis A	Elastin and collagen fibre microstructure of the human aorta in ageing and disease: a review.	Journal of the Royal Society, Interface	2013	31
24365767	2006	Gilpin SE	Perfusion decellularization of human and porcine lungs: bringing the matrix to clinical scale.	The Journal of heart and lung transplantation 	2014	41
26293758	2006	Guzzardi DG	Valve-Related Hemodynamics Mediate Human Bicuspid Aortopathy: Insights From Wall Shear Stress Mapping.	Journal of the American College of Cardiology	2015	23
1326540	2022	Cheifetz S	Endoglin is a component of the transforming growth factor-beta receptor system in human endothelial cells.	The Journal of biological chemistry	1992	162
14578181	2022	Baluk P	Abnormalities of basement membrane on blood vessels and endothelial sprouts in tumors.	The American journal of pathology	2003	91
20424116	2022	Hawinkels LJ	Matrix metalloproteinase-14 (MT1-MMP)-mediated endoglin shedding inhibits tumor angiogenesis.	Cancer research	2010	59
20644016	2022	Noori M	Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.	Circulation	2010	57
23437230	2022	Tannetta DS	Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin.	PloS one	2013	29
12663857	2056	Calvillo L	Recombinant human erythropoietin protects the myocardium from ischemia-reperfusion injury and promotes beneficial remodeling.	Proceedings of the National Academy of Sciences of the United States of America	2003	85
14525788	2056	Bahlmann FH	Erythropoietin regulates endothelial progenitor cells.	Blood	2004	76
17576662	2056	Westenbrink BD	Erythropoietin improves cardiac function through endothelial progenitor cell and vascular endothelial growth factor mediated neovascularization.	European heart journal	2007	56
18324962	2056	Arcasoy MO	The non-haematopoietic biological effects of erythropoietin.	British journal of haematology	2008	78
18466917	2056	Robey TE	Systems approaches to preventing transplanted cell death in cardiac repair.	Journal of molecular and cellular cardiology	2008	106
21558517	2056	Najjar SS	Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial.	JAMA	2011	53
21900080	2056	Sachdev V	Echocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.	Circulation	2011	36
20034863	2078	Braam SR	Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes.	Stem cell research	2010	90
22028871	2078	Schaaf S	Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology.	PloS one	2011	77
22052944	2078	Lahti AL	Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture.	Disease models and mechanisms	2012	86
23690542	2078	Harris K	Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays.	Toxicological sciences 	2013	29
24030418	2078	Navarrete EG	Screening drug-induced arrhythmia corrected using human induced pluripotent stem cell-derived cardiomyocytes and low-impedance microelectrode arrays.	Circulation	2013	52
25540418	2078	Morita R	ETS transcription factor ETV2 directly converts human fibroblasts into functional endothelial cells.	Proceedings of the National Academy of Sciences of the United States of America	2015	20
26170255	2078	Fermini B	A New Perspective in the Field of Cardiac Safety Testing through the Comprehensive In Vitro Proarrhythmia Assay Paradigm.	Journal of biomolecular screening	2016	21
26785135	2078	Eng G	Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes.	Nature communications	2016	14
2889967	2147	Radomski MW	Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium.	Lancet	1987	170
9348075	2147	Maruyama T	2APB, 2-aminoethoxydiphenyl borate, a membrane-penetrable modulator of Ins(1,4,5)P3-induced Ca2+ release.	Journal of biochemistry	1997	206
11341498	2147	Berckmans RJ	Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation.	Thrombosis and haemostasis	2001	94
14709404	2147	Birukova AA	Role of Rho GTPases in thrombin-induced lung vascular endothelial cells barrier dysfunction.	Microvascular research	2004	86
16257999	2147	Birukova AA	GEF-H1 is involved in agonist-induced human pulmonary endothelial barrier dysfunction.	American journal of physiology. Lung cellular and molecular physiology	2006	66
19220204	2147	Vanhoutte PM	Endothelial dysfunction and vascular disease.	Acta physiologica	2009	122
25660055	2147	Stakos DA	Expression of functional tissue factor by neutrophil extracellular traps in culprit artery of acute myocardial infarction.	European heart journal	2015	23
12805058	2152	Shet AS	Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes.	Blood	2003	125
16461845	2152	Steffel J	Tissue factor in cardiovascular diseases: molecular mechanisms and clinical implications.	Circulation	2006	80
22390643	2152	Tuttolomondo A	Atherosclerosis as an inflammatory disease.	Current pharmaceutical design	2012	44
10187889	2244	Ebrahim S	Carotid plaque, intima media thickness, cardiovascular risk factors, and prevalent cardiovascular disease in men and women: the British Regional Heart Study.	Stroke	1999	100
10862640	2244	Guérin AP	Arterial stiffening and vascular calcifications in end-stage renal disease.	Nephrology, dialysis, transplantation 	2000	95
15041083	2244	Steptoe A	Loneliness and neuroendocrine, cardiovascular, and inflammatory stress responses in middle-aged men and women.	Psychoneuroendocrinology	2004	85
16723443	2244	Wong TY	Retinal vascular caliber, cardiovascular risk factors, and inflammation: the multi-ethnic study of atherosclerosis (MESA).	Investigative ophthalmology and visual science	2006	92
17485598	2244	Roman MJ	Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the Strong Heart Study.	Hypertension	2007	132
22253320	2244	McGuinness D	Socio-economic status is associated with epigenetic differences in the pSoBid cohort.	International journal of epidemiology	2012	33
23249928	2244	Rahe-Meyer N	Effects of fibrinogen concentrate as first-line therapy during major aortic replacement surgery: a randomized, placebo-controlled trial.	Anesthesiology	2013	31
24335500	2244	Cines DB	Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin.	Blood	2014	23
24691204	2244	Longenecker CT	Soluble CD14 is independently associated with coronary calcification and extent of subclinical vascular disease in treated HIV infection.	AIDS	2014	44
8626565	2247	Whitelock JM	The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases.	The Journal of biological chemistry	1996	119
18220619	2247	Simó R	Angiogenic and antiangiogenic factors in proliferative diabetic retinopathy.	Current diabetes reviews	2006	75
18232728	2247	Pietras K	Functions of paracrine PDGF signaling in the proangiogenic tumor stroma revealed by pharmacological targeting.	PLoS medicine	2008	105
19038683	2247	Takehara N	Controlled delivery of basic fibroblast growth factor promotes human cardiosphere-derived cell engraftment to enhance cardiac repair for chronic myocardial infarction.	Journal of the American College of Cardiology	2008	52
19197140	2247	Izikki M	Endothelial-derived FGF2 contributes to the progression of pulmonary hypertension in humans and rodents.	The Journal of clinical investigation	2009	49
21494607	2247	Burridge PW	A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability.	PloS one	2011	120
22188562	2247	Hsiao ST	Comparative analysis of paracrine factor expression in human adult mesenchymal stem cells derived from bone marrow, adipose, and dermal tissue.	Stem cells and development	2012	58
24481949	2247	Ricard N	Increased pericyte coverage mediated by endothelial-derived fibroblast growth factor-2 and interleukin-6 is a source of smooth muscle-like cells in pulmonary hypertension.	Circulation	2014	23
24960162	2247	Bertero T	Systems-level regulation of microRNA networks by miR-130/301 promotes pulmonary hypertension.	The Journal of clinical investigation	2014	43
7929268	2321	Park JE	Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR.	The Journal of biological chemistry	1994	149
8605350	2321	Barleon B	Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1.	Blood	1996	207
11734454	2321	Bhatt AJ	Disrupted pulmonary vasculature and decreased vascular endothelial growth factor, Flt-1, and TIE-2 in human infants dying with bronchopulmonary dysplasia.	American journal of respiratory and critical care medicine	2001	115
19900040	2321	Kusanovic JP	A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia.	The journal of maternal-fetal and neonatal medicine 	2009	67
2445780	2335	Nathan CF	Neutrophil activation on biological surfaces. Massive secretion of hydrogen peroxide in response to products of macrophages and lymphocytes.	The Journal of clinical investigation	1987	164
2589440	2335	Roberts JM	Preeclampsia: an endothelial cell disorder.	American journal of obstetrics and gynecology	1989	178
8335696	2335	DiMilla PA	Maximal migration of human smooth muscle cells on fibronectin and type IV collagen occurs at an intermediate attachment strength.	The Journal of cell biology	1993	143
10353737	2335	Brown LF	Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast.	Clinical cancer research 	1999	96
10751360	2335	Kim S	Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin.	The American journal of pathology	2000	135
12451003	2335	Tepper OM	Human endothelial progenitor cells from type II diabetics exhibit impaired proliferation, adhesion, and incorporation into vascular structures.	Circulation	2002	300
15020515	2335	Boldt A	Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease.	Heart	2004	75
22293174	2335	Salmon H	Matrix architecture defines the preferential localization and migration of T cells into the stroma of human lung tumors.	The Journal of clinical investigation	2012	37
23261219	2335	Rao C	The effect of microgrooved culture substrates on calcium cycling of cardiac myocytes derived from human induced pluripotent stem cells.	Biomaterials	2013	30
24615475	2335	Rodriguez ML	Measuring the contractile forces of human induced pluripotent stem cell-derived cardiomyocytes with arrays of microposts.	Journal of biomechanical engineering	2014	26
12668503	2475	Shioi T	Rapamycin attenuates load-induced cardiac hypertrophy in mice.	Circulation	2003	116
15184287	2475	McMullen JR	Inhibition of mTOR signaling with rapamycin regresses established cardiac hypertrophy induced by pressure overload.	Circulation	2004	133
16769083	2475	Khan S	Rapamycin confers preconditioning-like protection against ischemia-reperfusion injury in isolated mouse heart and cardiomyocytes.	Journal of molecular and cellular cardiology	2006	64
17463046	2475	Roos S	Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth.	The Journal of physiology	2007	68
18559509	2475	Wang L	Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells.	Cancer research	2008	59
19103993	2475	Zhu W	Acute doxorubicin cardiotoxicity is associated with p53-induced inhibition of the mammalian target of rapamycin pathway.	Circulation	2009	50
19223493	2475	Yu G	Overexpression of phosphorylated mammalian target of rapamycin predicts lymph node metastasis and prognosis of chinese patients with gastric cancer.	Clinical cancer research 	2009	47
20082935	2475	Buss SJ	Beneficial effects of Mammalian target of rapamycin inhibition on left ventricular remodeling after myocardial infarction.	Journal of the American College of Cardiology	2009	50
20977912	2475	Shinmura K	Impact of long-term caloric restriction on cardiac senescence: caloric restriction ameliorates cardiac diastolic dysfunction associated with aging.	Journal of molecular and cellular cardiology	2011	46
21840335	2475	Speakman JR	Caloric restriction.	Molecular aspects of medicine	2011	138
22612226	2475	van Vliet EA	Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood-brain barrier leakage but not microglia activation.	Epilepsia	2012	33
23165769	2475	Rosario FJ	Mammalian target of rapamycin signalling modulates amino acid uptake by regulating transporter cell surface abundance in primary human trophoblast cells.	The Journal of physiology	2013	35
23601105	2475	Chang HH	A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity.	Cell host and microbe	2013	28
23686371	2475	Sen S	Glucose regulation of load-induced mTOR signaling and ER stress in mammalian heart.	Journal of the American Heart Association	2013	31
24270265	2475	Goncharov DA	Mammalian target of rapamycin complex 2 (mTORC2) coordinates pulmonary artery smooth muscle cell metabolism, proliferation, and survival in pulmonary arterial hypertension.	Circulation	2014	32
24481845	2475	Sciarretta S	Mammalian target of rapamycin signaling in cardiac physiology and disease.	Circulation research	2014	66
25282103	2475	Wood AR	Defining the role of common variation in the genomic and biological architecture of adult human height.	Nature genetics	2014	268
9568714	2626	Molkentin JD	A calcineurin-dependent transcriptional pathway for cardiac hypertrophy.	Cell	1998	559
11777997	2626	Quaini F	Chimerism of the transplanted heart.	The New England journal of medicine	2002	186
12668514	2626	Takahashi T	Ascorbic acid enhances differentiation of embryonic stem cells into cardiac myocytes.	Circulation	2003	91
16186259	2626	Tomita Y	Cardiac neural crest cells contribute to the dormant multipotent stem cell in the mammalian heart.	The Journal of cell biology	2005	75
18420831	2626	Hida N	Novel cardiac precursor-like cells from human menstrual blood-derived mesenchymal cells.	Stem cells	2008	65
22522929	2626	Qian L	In vivo reprogramming of murine cardiac fibroblasts into induced cardiomyocytes.	Nature	2012	323
23487791	2626	Nam YJ	Reprogramming of human fibroblasts toward a cardiac fate.	Proceedings of the National Academy of Sciences of the United States of America	2013	114
23839576	2626	Xin M	Mending broken hearts: cardiac development as a basis for adult heart regeneration and repair.	Nature reviews. Molecular cell biology	2013	90
10974216	2697	Boyett MR	The sinoatrial node, a heterogeneous pacemaker structure.	Cardiovascular research	2000	104
12742992	2697	Mummery C	Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells.	Circulation	2003	243
15576650	2697	Ai X	Connexin 43 downregulation and dephosphorylation in nonischemic heart failure is associated with enhanced colocalized protein phosphatase type 2A.	Circulation research	2005	70
18064002	2697	Roell W	Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia.	Nature	2007	122
19786631	2697	Zwi L	Cardiomyocyte differentiation of human induced pluripotent stem cells.	Circulation	2009	107
19959133	2697	Girmatsion Z	Changes in microRNA-1 expression and IK1 up-regulation in human atrial fibrillation.	Heart rhythm	2009	46
20037143	2697	Bai X	Both cultured and freshly isolated adipose tissue-derived stem cells enhance cardiac function after acute myocardial infarction.	European heart journal	2010	46
20038810	2697	Smyth JW	Limited forward trafficking of connexin 43 reduces cell-cell coupling in stressed human and mouse myocardium.	The Journal of clinical investigation	2010	74
20093630	2697	Glukhov AV	Transmural dispersion of repolarization in failing and nonfailing human ventricle.	Circulation research	2010	89
20606116	2697	Thibodeau IL	Paradigm of genetic mosaicism and lone atrial fibrillation: physiological characterization of a connexin 43-deletion mutant identified from atrial tissue.	Circulation	2010	44
21744185	2697	Duan Y	Hybrid gel composed of native heart matrix and collagen induces cardiac differentiation of human embryonic stem cells without supplemental growth factors.	Journal of cardiovascular translational research	2011	35
21819962	2697	Márquez-Rosado L	Connexin43 phosphorylation in brain, cardiac, endothelial and epithelial tissues.	Biochimica et biophysica acta	2012	41
23178689	2697	Noorman M	Remodeling of the cardiac sodium channel, connexin43, and plakoglobin at the intercalated disk in patients with arrhythmogenic cardiomyopathy.	Heart rhythm	2013	32
23461462	2697	Lundy SD	Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells.	Stem cells and development	2013	129
24852842	2697	Hirt MN	Functional improvement and maturation of rat and human engineered heart tissue by chronic electrical stimulation.	Journal of molecular and cellular cardiology	2014	41
25654582	2697	Beauchamp P	Development and Characterization of a Scaffold-Free 3D Spheroid Model of Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes.	Tissue engineering. Part C, Methods	2015	18
26291556	2697	Riegler J	Human Engineered Heart Muscles Engraft and Survive Long Term in a Rodent Myocardial Infarction Model.	Circulation research	2015	27
26516000	2697	Nademanee K	Fibrosis, Connexin-43, and Conduction Abnormalities in the Brugada Syndrome.	Journal of the American College of Cardiology	2015	19
7641334	3091	Liu Y	Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells. Identification of a 5' enhancer.	Circulation research	1995	163
9436976	3091	Iyer NV	Cellular and developmental control of O2 homeostasis by hypoxia-inducible factor 1 alpha.	Genes and development	1998	518
10699162	3091	Lee SH	Early expression of angiogenesis factors in acute myocardial ischemia and infarction.	The New England journal of medicine	2000	107
15498848	3091	Hong KH	Monocyte chemoattractant protein-1-induced angiogenesis is mediated by vascular endothelial growth factor-A.	Blood	2005	71
16452478	3091	Ullah MS	The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1alpha-dependent mechanism.	The Journal of biological chemistry	2006	157
17015745	3091	Argaw AT	IL-1beta regulates blood-brain barrier permeability via reactivation of the hypoxia-angiogenesis program.	Journal of immunology	2006	62
20110409	3091	Fijalkowska I	Hypoxia inducible-factor1alpha regulates the metabolic shift of pulmonary hypertensive endothelial cells.	The American journal of pathology	2010	72
23509326	3091	Lundgrin EL	Fasting 2-deoxy-2-18Ffluoro-D-glucose positron emission tomography to detect metabolic changes in pulmonary arterial hypertension hearts over 1 year.	Annals of the American Thoracic Society	2013	31
9537338	3156	Laufs U	Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors.	Circulation	1998	216
12672737	3156	Thompson PD	Statin-associated myopathy.	JAMA	2003	174
17640385	3156	Wolozin B	Simvastatin is associated with a reduced incidence of dementia and Parkinson's disease.	BMC medicine	2007	64
9622162	3162	De Keulenaer GW	Oscillatory and steady laminar shear stress differentially affect human endothelial redox state: role of a superoxide-producing NADH oxidase.	Circulation research	1998	117
12130498	3162	Jeney V	Pro-oxidant and cytotoxic effects of circulating heme.	Blood	2002	116
16408059	3162	Bryan NS	Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues.	Nature chemical biology	2005	111
17413033	3162	Krönke G	Expression of heme oxygenase-1 in human vascular cells is regulated by peroxisome proliferator-activated receptors.	Arteriosclerosis, thrombosis, and vascular biology	2007	58
19937043	3162	Schrag M	Correlation of hypointensities in susceptibility-weighted images to tissue histology in dementia patients with cerebral amyloid angiopathy: a postmortem MRI study.	Acta neuropathologica	2010	54
22879597	3162	Cai C	The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release.	The Journal of biological chemistry	2012	39
1361507	3383	Ades EW	HMEC-1: establishment of an immortalized human microvascular endothelial cell line.	The Journal of investigative dermatology	1992	283
2566624	3383	Smith CW	Cooperative interactions of LFA-1 and Mac-1 with intercellular adhesion molecule-1 in facilitating adherence and transendothelial migration of human neutrophils in vitro.	The Journal of clinical investigation	1989	203
7542286	3383	De Caterina R	Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines.	The Journal of clinical investigation	1995	226
8476577	3383	Bevilacqua MP	Endothelial-leukocyte adhesion molecules.	Annual review of immunology	1993	186
9347951	3383	Newbold C	Receptor-specific adhesion and clinical disease in Plasmodium falciparum.	The American journal of tropical medicine and hygiene	1997	117
10393703	3383	Combes V	In vitro generation of endothelial microparticles and possible prothrombotic activity in patients with lupus anticoagulant.	The Journal of clinical investigation	1999	124
10433933	3383	Silamut K	A quantitative analysis of the microvascular sequestration of malaria parasites in the human brain.	The American journal of pathology	1999	125
10545519	3383	Peled A	The chemokine SDF-1 stimulates integrin-mediated arrest of CD34(+) cells on vascular endothelium under shear flow.	The Journal of clinical investigation	1999	113
11108718	3383	Kim I	Vascular endothelial growth factor expression of intercellular adhesion molecule 1 (ICAM-1), vascular cell adhesion molecule 1 (VCAM-1), and E-selectin through nuclear factor-kappa B activation in endothelial cells.	The Journal of biological chemistry	2001	142
11854119	3383	Ziccardi P	Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year.	Circulation	2002	131
11923038	3383	Nappo F	Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: role of fat and carbohydrate meals.	Journal of the American College of Cardiology	2002	90
15021878	3383	Schenkel AR	Locomotion of monocytes on endothelium is a critical step during extravasation.	Nature immunology	2004	103
15113816	3383	Meigs JB	Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus.	JAMA	2004	128
15811956	3383	Yang L	ICAM-1 regulates neutrophil adhesion and transcellular migration of TNF-alpha-activated vascular endothelium under flow.	Blood	2005	150
16935624	3383	Huang J	Inflammation in stroke and focal cerebral ischemia.	Surgical neurology	2006	133
16973825	3383	Csiszar A	Resveratrol attenuates TNF-alpha-induced activation of coronary arterial endothelial cells: role of NF-kappaB inhibition.	American journal of physiology. Heart and circulatory physiology	2006	88
19307690	3383	Lawson C	ICAM-1 signaling in endothelial cells.	Pharmacological reports 	2009	133
19910332	3383	Sauvet F	Effect of acute sleep deprivation on vascular function in healthy subjects.	Journal of applied physiology	2010	43
21164106	3383	Rautou PE	Microparticles from human atherosclerotic plaques promote endothelial ICAM-1-dependent monocyte adhesion and transendothelial migration.	Circulation research	2011	40
21852557	3383	Rautou PE	Microparticles, vascular function, and atherothrombosis.	Circulation research	2011	63
26152369	3383	O'Carroll SJ	Pro-inflammatory TNFα and IL-1β differentially regulate the inflammatory phenotype of brain microvascular endothelial cells.	Journal of neuroinflammation	2015	20
3877078	3552	Bevilacqua MP	Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes, and related leukocyte cell lines.	The Journal of clinical investigation	1985	204
8496693	3552	Taub DD	Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells.	The Journal of experimental medicine	1993	178
20081871	3552	Sims JE	The IL-1 family: regulators of immunity.	Nature reviews. Immunology	2010	231
22945591	3552	Rock KL	Uric acid as a danger signal in gout and its comorbidities.	Nature reviews. Rheumatology	2013	38
24321195	3552	Shinde AV	Fibroblasts in myocardial infarction: a role in inflammation and repair.	Journal of molecular and cellular cardiology	2014	60
26837745	3552	Ridker PM	From C-Reactive Protein to Interleukin-6 to Interleukin-1: Moving Upstream To Identify Novel Targets for Atheroprotection.	Circulation research	2016	23
27340270	3552	Prabhu SD	The Biological Basis for Cardiac Repair After Myocardial Infarction: From Inflammation to Fibrosis.	Circulation research	2016	31
10430608	3553	Frantz S	Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium.	The Journal of clinical investigation	1999	106
11489912	3553	Lindemann S	Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis.	The Journal of cell biology	2001	97
14581396	3553	Mazurek T	Human epicardial adipose tissue is a source of inflammatory mediators.	Circulation	2003	266
21159789	3553	Skulas-Ray AC	Dose-response effects of omega-3 fatty acids on triglycerides, inflammation, and endothelial function in healthy persons with moderate hypertriglyceridemia.	The American journal of clinical nutrition	2011	51
21599903	3553	Brochu ME	Developmental regulation of the neuroinflammatory responses to LPS and/or hypoxia-ischemia between preterm and term neonates: An experimental study.	Journal of neuroinflammation	2011	36
21945322	3553	Rieder F	Inflammation-induced endothelial-to-mesenchymal transition: a novel mechanism of intestinal fibrosis.	The American journal of pathology	2011	60
22219513	3553	Csiszar A	Age-associated proinflammatory secretory phenotype in vascular smooth muscle cells from the non-human primate Macaca mulatta: reversal by resveratrol treatment.	The journals of gerontology. Series A, Biological sciences and medical sciences	2012	39
22829270	3553	Librizzi L	Seizure-induced brain-borne inflammation sustains seizure recurrence and blood-brain barrier damage.	Annals of neurology	2012	37
24446952	3553	Rojas A	Cyclooxygenase-2 in epilepsy.	Epilepsia	2014	21
24920309	3553	Jansson D	A role for human brain pericytes in neuroinflammation.	Journal of neuroinflammation	2014	20
9389420	3569	Pickup JC	NIDDM as a disease of the innate immune system: association of acute-phase reactants and interleukin-6 with metabolic syndrome X.	Diabetologia	1997	150
9398739	3569	Mohamed-Ali V	Subcutaneous adipose tissue releases interleukin-6, but not tumor necrosis factor-alpha, in vivo.	The Journal of clinical endocrinology and metabolism	1997	276
11388092	3569	Pinede L	Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases.	Medicine	2001	92
16120716	3569	Minoguchi K	Increased carotid intima-media thickness and serum inflammatory markers in obstructive sleep apnea.	American journal of respiratory and critical care medicine	2005	85
16412224	3569	Baker AR	Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease.	Cardiovascular diabetology	2006	121
16613757	3569	Bastard JP	Recent advances in the relationship between obesity, inflammation, and insulin resistance.	European cytokine network	2006	383
17446340	3569	Törnqvist H	Persistent endothelial dysfunction in humans after diesel exhaust inhalation.	American journal of respiratory and critical care medicine	2007	94
17654441	3569	Hartge MM	The endothelium and vascular inflammation in diabetes.	Diabetes and vascular disease research	2007	55
17716366	3569	Jeschke MG	Burn size determines the inflammatory and hypermetabolic response.	Critical care	2007	58
18220642	3569	Hamdy O	Metabolic obesity: the paradox between visceral and subcutaneous fat.	Current diabetes reviews	2006	96
18926166	3569	Libby P	Role of inflammation in atherosclerosis associated with rheumatoid arthritis.	The American journal of medicine	2008	54
19122178	3569	Chatterjee TK	Proinflammatory phenotype of perivascular adipocytes: influence of high-fat feeding.	Circulation research	2009	112
19268915	3569	Lindqvist D	Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.	Biological psychiatry	2009	93
19289637	3569	Greenstein AS	Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients.	Circulation	2009	113
19318968	3569	Tarantino G	Could inflammatory markers help diagnose nonalcoholic steatohepatitis?	European journal of gastroenterology and hepatology	2009	46
22146091	3569	Pervanidou P	Metabolic consequences of stress during childhood and adolescence.	Metabolism	2012	45
22743373	3569	Ostrowski SR	Endothelial glycocalyx degradation induces endogenous heparinization in patients with severe injury and early traumatic coagulopathy.	The journal of trauma and acute care surgery	2012	36
24033321	3569	Patel AR	Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.	American journal of respiratory and critical care medicine	2013	30
24728071	3569	Miller CJ	Adjudicated morbidity and mortality outcomes by age among individuals with HIV infection on suppressive antiretroviral therapy.	PloS one	2014	22
26781070	3569	Domingueti CP	Diabetes mellitus: The linkage between oxidative stress, inflammation, hypercoagulability and vascular complications.	Journal of diabetes and its complications	2016	18
26858430	3569	Morris CJ	Circadian misalignment increases cardiovascular disease risk factors in humans.	Proceedings of the National Academy of Sciences of the United States of America	2016	16
1281554	3576	Koch AE	Interleukin-8 as a macrophage-derived mediator of angiogenesis.	Science	1992	310
12496258	3576	Heidemann J	Angiogenic effects of interleukin 8 (CXCL8) in human intestinal microvascular endothelial cells are mediated by CXCR2.	The Journal of biological chemistry	2003	117
12626597	3576	Li A	IL-8 directly enhanced endothelial cell survival, proliferation, and matrix metalloproteinases production and regulated angiogenesis.	Journal of immunology	2003	238
16195477	3576	Henrichot E	Production of chemokines by perivascular adipose tissue: a role in the pathogenesis of atherosclerosis?	Arteriosclerosis, thrombosis, and vascular biology	2005	77
17431490	3576	Gojova A	Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: effect of particle composition.	Environmental health perspectives	2007	61
19035451	3576	Matsuo Y	CXCL8/IL-8 and CXCL12/SDF-1alpha co-operatively promote invasiveness and angiogenesis in pancreatic cancer.	International journal of cancer	2009	68
20092409	3576	Jain SK	Low levels of hydrogen sulfide in the blood of diabetes patients and streptozotocin-treated rats causes vascular inflammation?	Antioxidants and redox signaling	2010	51
22090163	3576	Dweck MR	Assessment of valvular calcification and inflammation by positron emission tomography in patients with aortic stenosis.	Circulation	2012	40
22516444	3576	Dweck MR	Coronary arterial 18F-sodium fluoride uptake: a novel marker of plaque biology.	Journal of the American College of Cardiology	2012	51
2044434	3630	DeFronzo RA	Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.	Diabetes care	1991	373
7839388	3630	Sacco RL	Race-ethnicity and determinants of intracranial atherosclerotic cerebral infarction. The Northern Manhattan Stroke Study.	Stroke	1995	138
12551870	3630	Rutter MK	Impact of glucose intolerance and insulin resistance on cardiac structure and function: sex-related differences in the Framingham Heart Study.	Circulation	2003	97
15123530	3630	Peterson LR	Effect of obesity and insulin resistance on myocardial substrate metabolism and efficiency in young women.	Circulation	2004	122
15655131	3630	Antzelevitch C	Brugada syndrome: report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.	Circulation	2005	210
16644702	3630	Clerk LH	Obesity blunts insulin-mediated microvascular recruitment in human forearm muscle.	Diabetes	2006	80
16813742	3630	Ness RB	Shared and disparate components of the pathophysiologies of fetal growth restriction and preeclampsia.	American journal of obstetrics and gynecology	2006	79
17145742	3630	Kahn SE	Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy.	The New England journal of medicine	2006	516
18319352	3630	Dubé JJ	Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited.	American journal of physiology. Endocrinology and metabolism	2008	94
20802107	3630	Burt Solorzano CM	Obesity and the pubertal transition in girls and boys.	Reproduction	2010	52
20978091	3630	Schauer IE	Insulin resistance, defective insulin-mediated fatty acid suppression, and coronary artery calcification in subjects with and without type 1 diabetes: The CACTI study.	Diabetes	2011	48
21050286	3630	Caesar R	Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism.	Journal of internal medicine	2010	42
23099275	3630	Kwon KC	Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells.	Advanced drug delivery reviews	2013	35
23144651	3630	Chen E	"Shift-and-Persist" Strategies: Why Low Socioeconomic Status Isn't Always Bad for Health.	Perspectives on psychological science 	2012	39
23164767	3630	Jacobi J	Guidelines for the use of an insulin infusion for the management of hyperglycemia in critically ill patients.	Critical care medicine	2012	64
23885014	3630	Manrique C	Obesity and insulin resistance induce early development of diastolic dysfunction in young female mice fed a Western diet.	Endocrinology	2013	35
24250251	3630	Rajendran P	The vascular endothelium and human diseases.	International journal of biological sciences	2013	62
24529130	3630	Alexopoulos N	Visceral adipose tissue as a source of inflammation and promoter of atherosclerosis.	Atherosclerosis	2014	31
24650277	3630	Manrique C	New insights into insulin action and resistance in the vasculature.	Annals of the New York Academy of Sciences	2014	20
24757202	3630	Chow E	Risk of cardiac arrhythmias during hypoglycemia in patients with type 2 diabetes and cardiovascular risk.	Diabetes	2014	33
25766618	3630	Kim B	Insulin resistance as a key link for the increased risk of cognitive impairment in the metabolic syndrome.	Experimental and molecular medicine	2015	20
26549485	3630	Tian XY	Thermoneutral Housing Accelerates Metabolic Inflammation to Potentiate Atherosclerosis but Not Insulin Resistance.	Cell metabolism	2016	13
26678809	3630	Jia G	Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy.	Nature reviews. Endocrinology	2016	25
26863521	3630	Ho JE	Metabolomic Profiles of Body Mass Index in the Framingham Heart Study Reveal Distinct Cardiometabolic Phenotypes.	PloS one	2016	12
26886418	3630	Kernan WN	Pioglitazone after Ischemic Stroke or Transient Ischemic Attack.	The New England journal of medicine	2016	45
17596340	3741	Bonnet S	The nuclear factor of activated T cells in pulmonary arterial hypertension can be therapeutically targeted.	Proceedings of the National Academy of Sciences of the United States of America	2007	86
19949938	3741	Piao L	The inhibition of pyruvate dehydrogenase kinase improves impaired cardiac function and electrical remodeling in two models of right ventricular hypertrophy: resuscitating the hibernating right ventricle.	Journal of molecular medicine	2010	73
21921263	3741	Grandi E	Human atrial action potential and Ca2+ model: sinus rhythm and chronic atrial fibrillation.	Circulation research	2011	74
25700171	3741	Devalla HD	Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology.	EMBO molecular medicine	2015	29
8587608	3757	Smith PL	The inward rectification mechanism of the HERG cardiac potassium channel.	Nature	1996	194
8740374	3757	Spector PS	Fast inactivation causes rectification of the IKr channel.	The Journal of general physiology	1996	140
21240260	3757	Itzhaki I	Modelling the long QT syndrome with induced pluripotent stem cells.	Nature	2011	277
21367833	3757	Matsa E	Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.	European heart journal	2011	106
22988594	3757	Vandenberg JI	hERG K(+) channels: structure, function, and clinical significance.	Physiological reviews	2012	92
23277474	3757	Terrenoire C	Induced pluripotent stem cells used to reveal drug actions in a long QT syndrome family with complex genetics.	The Journal of general physiology	2013	52
23470493	3757	Matsa E	Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.	European heart journal	2014	28
24213244	3757	Bellin M	Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome.	The EMBO journal	2013	46
9804796	3791	Gerber HP	Vascular endothelial growth factor regulates endothelial cell survival through the phosphatidylinositol 3'-kinase/Akt signal transduction pathway. Requirement for Flk-1/KDR activation.	The Journal of biological chemistry	1998	366
9892193	3791	Fong TA	SU5416 is a potent and selective inhibitor of the vascular endothelial growth factor receptor (Flk-1/KDR) that inhibits tyrosine kinase catalysis, tumor vascularization, and growth of multiple tumor types.	Cancer research	1999	145
10022831	3791	Soldi R	Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2.	The EMBO journal	1999	118
11387210	3791	Takahashi T	A single autophosphorylation site on KDR/Flk-1 is essential for VEGF-A-dependent activation of PLC-gamma and DNA synthesis in vascular endothelial cells.	The EMBO journal	2001	170
11440984	3791	Vasa M	Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease.	Circulation research	2001	415
11719508	3791	Colavitti R	Reactive oxygen species as downstream mediators of angiogenic signaling by vascular endothelial growth factor receptor-2/KDR.	The Journal of biological chemistry	2002	82
12620408	3791	Bais C	Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR.	Cancer cell	2003	80
15308462	3791	Asahara T	Endothelial progenitor cells for postnatal vasculogenesis.	American journal of physiology. Cell physiology	2004	93
15862416	3791	Heiss C	Impaired progenitor cell activity in age-related endothelial dysfunction.	Journal of the American College of Cardiology	2005	103
15927972	3791	Schmidt-Lucke C	Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair.	Circulation	2005	201
17569886	3791	Ferreira LS	Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo.	Circulation research	2007	74
18063830	3791	Yip HK	Level and value of circulating endothelial progenitor cells in patients after acute ischemic stroke.	Stroke	2008	51
18559524	3791	Hilberg F	BIBF 1120: triple angiokinase inhibitor with sustained receptor blockade and good antitumor efficacy.	Cancer research	2008	123
18977327	3791	Würdinger T	miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells.	Cancer cell	2008	120
19007739	3791	Norden AD	Novel anti-angiogenic therapies for malignant gliomas.	The Lancet. Neurology	2008	50
19717420	3791	Bearzi C	Identification of a coronary vascular progenitor cell in the human heart.	Proceedings of the National Academy of Sciences of the United States of America	2009	70
21653826	3791	Herzog B	VEGF binding to NRP1 is essential for VEGF stimulation of endothelial cell migration, complex formation between NRP1 and VEGFR2, and signaling via FAK Tyr407 phosphorylation.	Molecular biology of the cell	2011	50
22718841	3791	Jiang T	CD146 is a coreceptor for VEGFR-2 in tumor angiogenesis.	Blood	2012	36
24765614	3791	Voron T	Control of the immune response by pro-angiogenic factors.	Frontiers in oncology	2014	31
25240821	3791	Wilke H	Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial.	The Lancet. Oncology	2014	184
16849646	3815	Poliseno L	MicroRNAs modulate the angiogenic properties of HUVECs.	Blood	2006	192
17709737	3815	Bearzi C	Human cardiac stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2007	296
18550634	3815	Urbich C	Role of microRNAs in vascular diseases, inflammation, and angiogenesis.	Cardiovascular research	2008	210
19852056	3815	Zimmerlin L	Stromal vascular progenitors in adult human adipose tissue.	Cytometry. Part A 	2010	109
20100033	3815	Seif-Naraghi SB	Design and characterization of an injectable pericardial matrix gel: a potentially autologous scaffold for cardiac tissue engineering.	Tissue engineering. Part A	2010	41
20629996	3815	Popescu LM	Telocytes in human epicardium.	Journal of cellular and molecular medicine	2010	55
21471108	3815	Montani D	C-kit-positive cells accumulate in remodeled vessels of idiopathic pulmonary arterial hypertension.	American journal of respiratory and critical care medicine	2011	39
21474103	3815	Loffredo FS	Bone marrow-derived cell therapy stimulates endogenous cardiomyocyte progenitors and promotes cardiac repair.	Cell stem cell	2011	142
21960726	3815	Leri A	Role of cardiac stem cells in cardiac pathophysiology: a paradigm shift in human myocardial biology.	Circulation research	2011	70
22381431	3815	Li TS	Direct comparison of different stem cell types and subpopulations reveals superior paracrine potency and myocardial repair efficacy with cardiosphere-derived cells.	Journal of the American College of Cardiology	2012	127
23371930	3815	Xiong Q	Functional consequences of human induced pluripotent stem cell therapy: myocardial ATP turnover rate in the in vivo swine heart with postinfarction remodeling.	Circulation	2013	30
24170267	3815	Sanada F	c-Kit-positive cardiac stem cells nested in hypoxic niches are activated by stem cell factor reversing the aging myopathy.	Circulation research	2014	29
24674389	3815	Yang Y	Telocytes in human heart valves.	Journal of cellular and molecular medicine	2014	24
24725987	3815	Lopatina T	Platelet-derived growth factor regulates the secretion of extracellular vesicles by adipose mesenchymal stem cells and enhances their angiogenic potential.	Cell communication and signaling 	2014	39
9588554	3827	Kroll RA	Outwitting the blood-brain barrier for therapeutic purposes: osmotic opening and other means.	Neurosurgery	1998	111
16365212	3827	Mills NL	Diesel exhaust inhalation causes vascular dysfunction and impaired endogenous fibrinolysis.	Circulation	2005	150
17200437	3827	Campbell WB	Arachidonic acid metabolites as endothelium-derived hyperpolarizing factors.	Hypertension	2007	71
19297385	3827	Antoniades C	Association of plasma asymmetrical dimethylarginine (ADMA) with elevated vascular superoxide production and endothelial nitric oxide synthase uncoupling: implications for endothelial function in human atherosclerosis.	European heart journal	2009	53
20224870	3827	Campbell WB	Epoxyeicosatrienoic acids and endothelium-dependent responses.	Pflugers Archiv 	2010	76
25791797	3827	van Tellingen O	Overcoming the blood-brain tumor barrier for effective glioblastoma treatment.	Drug resistance updates 	2015	28
12674330	4162	Shi S	Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp.	Journal of bone and mineral research 	2003	259
20649485	4162	Bianco P	"Mesenchymal" stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease.	Human gene therapy	2010	44
21861688	4162	Corselli M	The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells.	Stem cells and development	2012	81
22075475	4162	Spitzer TL	Perivascular human endometrial mesenchymal stem cells express pathways relevant to self-renewal, lineage specification, and functional phenotype.	Biology of reproduction	2012	36
23600480	4162	Blocki A	Not all MSCs can act as pericytes: functional in vitro assays to distinguish pericytes from other mesenchymal stem cells in angiogenesis.	Stem cells and development	2013	36
23349535	4306	Bender SB	Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?	Diabetes	2013	42
8958220	4313	Rajagopalan S	Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.	The Journal of clinical investigation	1996	164
11181465	4313	Crisby M	Pravastatin treatment increases collagen content and decreases lipid content, inflammation, metalloproteinases, and cell death in human carotid plaques: implications for plaque stabilization.	Circulation	2001	88
11839588	4313	Taraboletti G	Shedding of the matrix metalloproteinases MMP-2, MMP-9, and MT1-MMP as membrane vesicle-associated components by endothelial cells.	The American journal of pathology	2002	98
15545316	4313	Chun TH	MT1-MMP-dependent neovessel formation within the confines of the three-dimensional extracellular matrix.	The Journal of cell biology	2004	98
21454822	4313	Candelario-Jalil E	Matrix metalloproteinases are associated with increased blood-brain barrier opening in vascular cognitive impairment.	Stroke	2011	37
24281743	4313	Jickling GC	Hemorrhagic transformation after ischemic stroke in animals and humans.	Journal of cerebral blood flow and metabolism 	2014	38
19273718	4607	van Dijk SJ	Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction.	Circulation	2009	83
19574547	4607	Marston S	Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency.	Circulation research	2009	50
20850451	4607	Copeland O	Analysis of cardiac myosin binding protein-C phosphorylation in human heart muscle.	Journal of molecular and cellular cardiology	2010	47
23281406	4607	McNally EM	Genetic mutations and mechanisms in dilated cardiomyopathy.	The Journal of clinical investigation	2013	75
23508784	4607	Sequeira V	Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations.	Circulation research	2013	52
15047770	4843	Schrage WG	Local inhibition of nitric oxide and prostaglandins independently reduces forearm exercise hyperaemia in humans.	The Journal of physiology	2004	71
15364894	4843	Xu W	Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension.	FASEB journal 	2004	98
15774613	4843	Dejam A	Erythrocytes are the major intravascular storage sites of nitrite in human blood.	Blood	2005	79
25799991	4843	Lee DI	Phosphodiesterase 9A controls nitric-oxide-independent cGMP and hypertrophic heart disease.	Nature	2015	24
7540722	4846	Giaid A	Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension.	The New England journal of medicine	1995	175
9399960	4846	Papapetropoulos A	Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells.	The Journal of clinical investigation	1997	194
9727051	4846	Laufs U	Post-transcriptional regulation of endothelial nitric oxide synthase mRNA stability by Rho GTPase.	The Journal of biological chemistry	1998	174
12093770	4846	Takemoto M	Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase.	Circulation	2002	90
12270858	4846	Wallerath T	Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase.	Circulation	2002	94
14605020	4846	Gulati R	Diverse origin and function of cells with endothelial phenotype obtained from adult human blood.	Circulation research	2003	95
15276015	4846	Oudit GY	The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease.	Journal of molecular and cellular cardiology	2004	107
16585403	4846	Förstermann U	Endothelial nitric oxide synthase in vascular disease: from marvel to menace.	Circulation	2006	327
18382884	4846	Münzel T	Pathophysiology, diagnosis and prognostic implications of endothelial dysfunction.	Annals of medicine	2008	76
20159829	4846	Jelic S	Vascular inflammation in obesity and sleep apnea.	Circulation	2010	42
22079549	4846	Toda N	Age-related changes in endothelial function and blood flow regulation.	Pharmacology and therapeutics	2012	32
12225726	4879	Redfield MM	Plasma brain natriuretic peptide concentration: impact of age and gender.	Journal of the American College of Cardiology	2002	105
12892964	4879	de Lemos JA	B-type natriuretic peptide in cardiovascular disease.	Lancet	2003	103
18154959	4879	Daniels LB	Natriuretic peptides.	Journal of the American College of Cardiology	2007	127
18598886	4879	Anderson PA	Contemporary outcomes after the Fontan procedure: a Pediatric Heart Network multicenter study.	Journal of the American College of Cardiology	2008	61
18760965	4879	Maisel A	State of the art: using natriuretic peptide levels in clinical practice.	European journal of heart failure	2008	87
19329178	4879	Teerlink JR	Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.	Lancet	2009	70
23040568	4879	Akiyama E	Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction.	Journal of the American College of Cardiology	2012	36
23821090	4879	Ledwidge M	Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial.	JAMA	2013	39
24275629	4879	Matsuzawa Y	Peripheral endothelial function and cardiovascular events in high-risk patients.	Journal of the American Heart Association	2013	31
26056125	4879	Chung ES	Changes in ventricular remodelling and clinical status during the year following a single administration of stromal cell-derived factor-1 non-viral gene therapy in chronic ischaemic heart failure patients: the STOP-HF randomized Phase II trial.	European heart journal	2015	17
21701070	4973	Besler C	Mechanisms underlying adverse effects of HDL on eNOS-activating pathways in patients with coronary artery disease.	The Journal of clinical investigation	2011	107
17296677	5054	Cumashi A	A comparative study of the anti-inflammatory, anticoagulant, antiangiogenic, and antiadhesive activities of nine different fucoidans from brown seaweeds.	Glycobiology	2007	98
11917100	5175	Levenberg S	Endothelial cells derived from human embryonic stem cells.	Proceedings of the National Academy of Sciences of the United States of America	2002	147
11940546	5175	Atkinson C	Primary pulmonary hypertension is associated with reduced pulmonary vascular expression of type II bone morphogenetic protein receptor.	Circulation	2002	130
15111498	5175	Curat CA	From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes.	Diabetes	2004	116
15548691	5175	Hida K	Tumor-associated endothelial cells with cytogenetic abnormalities.	Cancer research	2004	97
16773076	5175	Des Guetz G	Microvessel density and VEGF expression are prognostic factors in colorectal cancer. Meta-analysis of the literature.	British journal of cancer	2006	78
17446880	5175	Duda DG	A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood.	Nature protocols	2007	76
18652940	5175	Joner M	Endothelial cell recovery between comparator polymer-based drug-eluting stents.	Journal of the American College of Cardiology	2008	76
18665180	5175	Beckermann BM	VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma.	British journal of cancer	2008	85
19389562	5175	Sluimer JC	Thin-walled microvessels in human coronary atherosclerotic plaques show incomplete endothelial junctions relevance of compromised structural integrity for intraplaque microvascular leakage.	Journal of the American College of Cardiology	2009	46
19642856	5175	Lesman A	Transplantation of a tissue-engineered human vascularized cardiac muscle.	Tissue engineering. Part A	2010	65
24412187	5175	Beer AJ	PET/CT imaging of integrin αvβ3 expression in human carotid atherosclerosis.	JACC. Cardiovascular imaging	2014	24
24467430	5175	Manetti M	A loss of telocytes accompanies fibrosis of multiple organs in systemic sclerosis.	Journal of cellular and molecular medicine	2014	24
12618519	5228	Maynard SE	Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia.	The Journal of clinical investigation	2003	642
17553534	5228	Mutter WP	Molecular mechanisms of preeclampsia.	Microvascular research	2008	68
21263663	5362	Zotter S	Visualization of microvasculature by dual-beam phase-resolved Doppler optical coherence tomography.	Optics express	2011	45
25230403	5362	Huang Y	Swept-source OCT angiography of the retinal vasculature using intensity differentiation-based optical microangiography algorithms.	Ophthalmic surgery, lasers and imaging retina	2014	36
25423628	5362	Moult E	Ultrahigh-speed swept-source OCT angiography in exudative AMD.	Ophthalmic surgery, lasers and imaging retina	2014	23
26255817	5362	Wang X	Correlation between optic disc perfusion and glaucomatous severity in patients with open-angle glaucoma: an optical coherence tomography angiography study.	Graefe's archive for clinical and experimental ophthalmology = Albrecht von Graefes Archiv fur klinische und experimentelle Ophthalmologie	2015	33
26457396	5362	Takase N	ENLARGEMENT OF FOVEAL AVASCULAR ZONE IN DIABETIC EYES EVALUATED BY EN FACE OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.	Retina	2015	19
26912261	5362	Zhang Q	Wide-field optical coherence tomography based microangiography for retinal imaging.	Scientific reports	2016	14
16157788	5972	Cornelissen VA	Effects of endurance training on blood pressure, blood pressure-regulating mechanisms, and cardiovascular risk factors.	Hypertension	2005	88
16197570	5972	Zittermann A	Putting cardiovascular disease and vitamin D insufficiency into perspective.	The British journal of nutrition	2005	71
17161262	5972	Rossi GP	A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.	Journal of the American College of Cardiology	2006	107
18256393	5972	Gaede P	Effect of a multifactorial intervention on mortality in type 2 diabetes.	The New England journal of medicine	2008	502
18823656	5972	Chaturvedi N	Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials.	Lancet	2008	66
19153265	5972	Solomon SD	Effect of the direct Renin inhibitor aliskiren, the Angiotensin receptor blocker losartan, or both on left ventricular mass in patients with hypertension and left ventricular hypertrophy.	Circulation	2009	52
19874988	5972	Triposkiadis F	The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.	Journal of the American College of Cardiology	2009	117
20515678	5972	Tomaschitz A	Independent association between 1,25-dihydroxyvitamin D, 25-hydroxyvitamin D and the renin-angiotensin system: The Ludwigshafen Risk and Cardiovascular Health (LURIC) study.	Clinica chimica acta; international journal of clinical chemistry	2010	43
22859525	5972	de Man FS	Dysregulated renin-angiotensin-aldosterone system contributes to pulmonary arterial hypertension.	American journal of respiratory and critical care medicine	2012	35
23121378	5972	Parving HH	Cardiorenal end points in a trial of aliskiren for type 2 diabetes.	The New England journal of medicine	2012	133
23358488	5972	Makani H	Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials.	BMJ	2013	26
25001649	5972	Iantorno M	Obesity, inflammation and endothelial dysfunction.	Journal of biological regulators and homeostatic agents	2014	23
25595565	5972	Goicoechea M	Allopurinol and progression of CKD and cardiovascular events: long-term follow-up of a randomized clinical trial.	American journal of kidney diseases 	2015	31
11157710	6262	Laitinen PJ	Mutations of the cardiac ryanodine receptor (RyR2) gene in familial polymorphic ventricular tachycardia.	Circulation	2001	112
20056922	6262	Neef S	CaMKII-dependent diastolic SR Ca2+ leak and elevated diastolic Ca2+ levels in right atrial myocardium of patients with atrial fibrillation.	Circulation research	2010	85
22174035	6262	Jung CB	Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.	EMBO molecular medicine	2012	90
22178870	6262	Fatima A	In vitro modeling of ryanodine receptor 2 dysfunction using human induced pluripotent stem cells.	Cellular physiology and biochemistry 	2011	59
22456474	6262	Voigt N	Enhanced sarcoplasmic reticulum Ca2+ leak and increased Na+-Ca2+ exchanger function underlie delayed afterdepolarizations in patients with chronic atrial fibrillation.	Circulation	2012	106
22749309	6262	Itzhaki I	Modeling of catecholaminergic polymorphic ventricular tachycardia with patient-specific human-induced pluripotent stem cells.	Journal of the American College of Cardiology	2012	60
22962621	6262	Kujala K	Cell model of catecholaminergic polymorphic ventricular tachycardia reveals early and delayed afterdepolarizations.	PloS one	2012	35
24563457	6262	Hwang HS	Divergent regulation of ryanodine receptor 2 calcium release channels by arrhythmogenic human calmodulin missense mutants.	Circulation research	2014	23
7651517	6331	Bennett PB	Molecular mechanism for an inherited cardiac arrhythmia.	Nature	1995	195
17060380	6331	Vatta M	Mutant caveolin-3 induces persistent late sodium current and is associated with long-QT syndrome.	Circulation	2006	137
18662191	6331	Moss AJ	Ranolazine shortens repolarization in patients with sustained inward sodium current due to type-3 long-QT syndrome.	Journal of cardiovascular electrophysiology	2008	53
20091048	6331	Amin AS	Cardiac sodium channelopathies.	Pflugers Archiv 	2010	45
20488304	6331	Sossalla S	Altered Na(+) currents in atrial fibrillation effects of ranolazine on arrhythmias and contractility in human atrial myocardium.	Journal of the American College of Cardiology	2010	53
21347284	6331	Smith JG	Genome-wide association studies of the PR interval in African Americans.	PLoS genetics	2011	41
22514276	6331	Ashpole NM	Ca2+/calmodulin-dependent protein kinase II (CaMKII) regulates cardiac sodium channel NaV1.5 gating by multiple phosphorylation sites.	The Journal of biological chemistry	2012	53
23123192	6331	Shy D	Cardiac sodium channel NaV1.5 distribution in myocytes via interacting proteins: the multiple pool model.	Biochimica et biophysica acta	2013	25
2466335	6401	Bevilacqua MP	Endothelial leukocyte adhesion molecule 1: an inducible receptor for neutrophils related to complement regulatory proteins and lectins.	Science	1989	347
22771675	6401	Eirin A	Inflammatory and injury signals released from the post-stenotic human kidney.	European heart journal	2013	35
7514509	6546	Luo CH	A dynamic model of the cardiac ventricular action potential. I. Simulations of ionic currents and concentration changes.	Circulation research	1994	259
7754383	6546	López-López JR	Local calcium transients triggered by single L-type calcium channel currents in cardiac cells.	Science	1995	171
10604883	7124	Ouchi N	Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin.	Circulation	1999	304
17339326	7124	Hamik A	Kruppel-like factor 4 regulates endothelial inflammation.	The Journal of biological chemistry	2007	115
17485581	7124	Maybaum S	Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.	Circulation	2007	64
17589522	7124	Connor KM	Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis.	Nature medicine	2007	189
17660390	7124	Rajesh M	CB2-receptor stimulation attenuates TNF-alpha-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion.	American journal of physiology. Heart and circulatory physiology	2007	70
18560012	7124	Miller DS	Modulation of P-glycoprotein at the blood-brain barrier: opportunities to improve central nervous system pharmacotherapy.	Pharmacological reviews	2008	76
18566296	7124	Apovian CM	Adipose macrophage infiltration is associated with insulin resistance and vascular endothelial dysfunction in obese subjects.	Arteriosclerosis, thrombosis, and vascular biology	2008	90
19229071	7124	Greif M	Pericardial adipose tissue determined by dual source CT is a risk factor for coronary atherosclerosis.	Arteriosclerosis, thrombosis, and vascular biology	2009	73
19421244	7124	McKellar GE	Role for TNF in atherosclerosis? Lessons from autoimmune disease.	Nature reviews. Cardiology	2009	52
19620518	7124	Brook RD	Insights into the mechanisms and mediators of the effects of air pollution exposure on blood pressure and vascular function in healthy humans.	Hypertension	2009	100
22887987	7124	Teo GS	Mesenchymal stem cells transmigrate between and directly through tumor necrosis factor-α-activated endothelial cells via both leukocyte-like and novel mechanisms.	Stem cells	2012	33
22955726	7124	Griep LM	BBB on chip: microfluidic platform to mechanically and biochemically modulate blood-brain barrier function.	Biomedical microdevices	2013	49
23095282	7124	Mäki-Petäjä KM	Anti-tumor necrosis factor-α therapy reduces aortic inflammation and stiffness in patients with rheumatoid arthritis.	Circulation	2012	32
23267561	7124	Christy AL	Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.	Journal of autoimmunity	2013	28
24968272	7124	Steyers CM 3rd	Endothelial dysfunction in chronic inflammatory diseases.	International journal of molecular sciences	2014	38
11489934	7137	Kehat I	Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes.	The Journal of clinical investigation	2001	298
18445579	7137	Zabrouskov V	Unraveling molecular complexity of phosphorylated human cardiac troponin I by top down electron capture dissociation/electron transfer dissociation mass spectrometry.	Molecular and cellular proteomics 	2008	55
20495811	7137	Thielmann M	Remote ischemic preconditioning reduces myocardial injury after coronary artery bypass surgery with crystalloid cardioplegic arrest.	Basic research in cardiology	2010	57
21751783	7137	Zhang J	Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure.	Journal of proteome research	2011	50
21965555	7137	Apple FS	Analytical characteristics of high-sensitivity cardiac troponin assays.	Clinical chemistry	2012	68
24829362	7137	Chin CW	High-sensitivity troponin I concentrations are a marker of an advanced hypertrophic response and adverse outcomes in patients with aortic stenosis.	European heart journal	2014	25
21139111	7139	de Lemos JA	Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population.	JAMA	2010	159
22370326	7139	Lipshultz SE	Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes.	Journal of clinical oncology 	2012	40
24930130	7139	Burridge PW	Chemically defined generation of human cardiomyocytes.	Nature methods	2014	137
7569978	7273	Labeit S	Titins: giant proteins in charge of muscle ultrastructure and elasticity.	Science	1995	221
10573426	7273	Marszalek PE	Mechanical unfolding intermediates in titin modules.	Nature	1999	183
11149943	7273	Oberhauser AF	Stepwise unfolding of titin under force-clamp atomic force microscopy.	Proceedings of the National Academy of Sciences of the United States of America	2001	89
11717165	7273	Bang ML	The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system.	Circulation research	2001	146
12198551	7273	Li H	Reverse engineering of the giant muscle protein titin.	Nature	2002	131
15238456	7273	Nagueh SF	Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy.	Circulation	2004	96
15345656	7273	Makarenko I	Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts.	Circulation research	2004	74
17475230	7273	Linke WA	Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction.	Cardiovascular research	2008	93
19179657	7273	Borbély A	Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium.	Circulation research	2009	71
19962384	7273	Barefield D	Phosphorylation and function of cardiac myosin binding protein-C in health and disease.	Journal of molecular and cellular cardiology	2010	89
22335739	7273	Herman DS	Truncations of titin causing dilated cardiomyopathy.	The New England journal of medicine	2012	183
24056688	7273	Rain S	Right ventricular diastolic impairment in patients with pulmonary arterial hypertension.	Circulation	2013	36
24503780	7273	Pugh TJ	The landscape of genetic variation in dilated cardiomyopathy as surveyed by clinical DNA sequencing.	Genetics in medicine 	2014	35
24625729	7273	Linke WA	Gigantic business: titin properties and function through thick and thin.	Circulation research	2014	44
24630725	7273	Alegre-Cebollada J	S-glutathionylation of cryptic cysteines enhances titin elasticity by blocking protein folding.	Cell	2014	31
25589632	7273	Roberts AM	Integrated allelic, transcriptional, and phenomic dissection of the cardiac effects of titin truncations in health and disease.	Science translational medicine	2015	35
26315439	7273	Hinson JT	HEART DISEASE. Titin mutations in iPS cells define sarcomere insufficiency as a cause of dilated cardiomyopathy.	Science	2015	50
1791831	7422	Houck KA	The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA.	Molecular endocrinology	1991	199
2479987	7422	Keck PJ	Vascular permeability factor, an endothelial cell mitogen related to PDGF.	Science	1989	279
7526212	7422	Aiello LP	Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.	The New England journal of medicine	1994	569
7673356	7422	Roberts WG	Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor.	Journal of cell science	1995	170
8167412	7422	Park JE	The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF.	Molecular biology of the cell	1993	181
8837607	7422	Gabrilovich DI	Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells.	Nature medicine	1996	271
9012841	7422	Möhle R	Constitutive production and thrombin-induced release of vascular endothelial growth factor by human megakaryocytes and platelets.	Proceedings of the National Academy of Sciences of the United States of America	1997	110
9377574	7422	Presta LG	Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.	Cancer research	1997	287
9529250	7422	Soker S	Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor.	Cell	1998	486
9707121	7422	Flore O	Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus.	Nature	1998	109
9916127	7422	Benjamin LE	Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal.	The Journal of clinical investigation	1999	225
10406801	7422	Asahara T	VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.	The EMBO journal	1999	299
10662790	7422	Yang TY	Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma.	The Journal of experimental medicine	2000	94
12124351	7422	Bates DO	VEGF165b, an inhibitory splice variant of vascular endothelial growth factor, is down-regulated in renal cell carcinoma.	Cancer research	2002	143
12177445	7422	Holash J	VEGF-Trap: a VEGF blocker with potent antitumor effects.	Proceedings of the National Academy of Sciences of the United States of America	2002	331
12642354	7422	Henry TD	The VIVA trial: Vascular endothelial growth factor in Ischemia for Vascular Angiogenesis.	Circulation	2003	161
14557356	7422	Britten MB	Infarct remodeling after intracoronary progenitor cell treatment in patients with acute myocardial infarction (TOPCARE-AMI): mechanistic insights from serial contrast-enhanced magnetic resonance imaging.	Circulation	2003	84
14993122	7422	Rehman J	Secretion of angiogenic and antiapoptotic factors by human adipose stromal cells.	Circulation	2004	362
16172288	7422	Khurana R	Role of angiogenesis in cardiovascular disease: a critical appraisal.	Circulation	2005	79
16490250	7422	Leach JK	Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration.	Biomaterials	2006	67
17475821	7422	Lindenmeyer MT	Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy.	Journal of the American Society of Nephrology 	2007	69
17533168	7422	Rigau V	Angiogenesis is associated with blood-brain barrier permeability in temporal lobe epilepsy.	Brain 	2007	69
17591953	7422	Nishijima K	Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury.	The American journal of pathology	2007	170
17636120	7422	Sayed N	Desensitization of soluble guanylyl cyclase, the NO receptor, by S-nitrosylation.	Proceedings of the National Academy of Sciences of the United States of America	2007	68
18452647	7422	Shibuya M	Vascular endothelial growth factor-dependent and -independent regulation of angiogenesis.	BMB reports	2008	52
19234476	7422	Augustin HG	Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system.	Nature reviews. Molecular cell biology	2009	292
20501804	7422	Hammers HJ	Reversible epithelial to mesenchymal transition and acquired resistance to sunitinib in patients with renal cell carcinoma: evidence from a xenograft study.	Molecular cancer therapeutics	2010	49
21167939	7422	Fidler IJ	The role of the organ microenvironment in brain metastasis.	Seminars in cancer biology	2011	63
21239704	7422	Stratman AN	VEGF and FGF prime vascular tube morphogenesis and sprouting directed by hematopoietic stem cell cytokines.	Blood	2011	38
21264342	7422	Rymo SF	A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures.	PloS one	2011	39
21323540	7422	Mintz-Hittner HA	Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity.	The New England journal of medicine	2011	124
21441136	7422	Li J	Orai1 and CRAC channel dependence of VEGF-activated Ca2+ entry and endothelial tube formation.	Circulation research	2011	51
21593862	7422	Carmeliet P	Molecular mechanisms and clinical applications of angiogenesis.	Nature	2011	810
21732485	7422	Horie N	Transplanted stem cell-secreted vascular endothelial growth factor effects poststroke recovery, inflammation, and vascular repair.	Stem cells	2011	61
22212972	7422	Stewart MW	The expanding role of vascular endothelial growth factor inhibitors in ophthalmology.	Mayo Clinic proceedings	2012	33
22399811	7422	dela Paz NG	Role of shear-stress-induced VEGF expression in endothelial cell survival.	Journal of cell science	2012	37
23856679	7422	Taimeh Z	Vascular endothelial growth factor in heart failure.	Nature reviews. Cardiology	2013	29
24013197	7422	Zangi L	Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction.	Nature biotechnology	2013	70
24949972	7422	Eswarappa SM	Programmed translational readthrough generates antiangiogenic VEGF-Ax.	Cell	2014	40
25220133	7422	Moja L	Systemic safety of bevacizumab versus ranibizumab for neovascular age-related macular degeneration.	The Cochrane database of systematic reviews	2014	27
25896459	7422	Ishibazawa A	Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study.	American journal of ophthalmology	2015	50
26137590	7422	Premer C	Allogeneic Mesenchymal Stem Cells Restore Endothelial Function in Heart Failure by Stimulating Endothelial Progenitor Cells.	EBioMedicine	2015	20
18347221	7450	Spiel AO	von Willebrand factor in cardiovascular disease: focus on acute coronary syndromes.	Circulation	2008	71
19246701	7450	Kearney-Schwartz A	Vascular structure and function is correlated to cognitive performance and white matter hyperintensities in older hypertensive patients with subjective memory complaints.	Stroke	2009	48
19181315	8074	Mirza MA	Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community.	Atherosclerosis	2009	90
19524924	8074	Mirza MA	Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population.	Atherosclerosis	2009	85
20176609	8074	Nasrallah MM	Fibroblast growth factor-23 (FGF-23) is independently correlated to aortic calcification in haemodialysis patients.	Nephrology, dialysis, transplantation 	2010	43
20613714	8074	Yilmaz MI	FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease.	Kidney international	2010	41
22492635	8074	Lim K	Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23.	Circulation	2012	99
22703926	8074	Ix JH	Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study).	Journal of the American College of Cardiology	2012	82
23389416	8074	Scialla JJ	Fibroblast growth factor 23 is not associated with and does not induce arterial calcification.	Kidney international	2013	54
25967123	8074	Isakova T	Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD.	Journal of the American Society of Nephrology 	2015	17
21036891	8654	Guazzi M	PDE5 inhibition with sildenafil improves left ventricular diastolic function, cardiac geometry, and clinical status in patients with stable systolic heart failure: results of a 1-year, prospective, randomized, placebo-controlled study.	Circulation. Heart failure	2011	74
10982546	9370	Ouchi N	Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway.	Circulation	2000	273
11752030	9370	Zoccali C	Adiponectin, metabolic risk factors, and cardiovascular events among patients with end-stage renal disease.	Journal of the American Society of Nephrology 	2002	91
12860835	9370	Ouchi N	Association of hypoadiponectinemia with impaired vasoreactivity.	Hypertension	2003	83
14557259	9370	Ouchi N	Adiponectin stimulates angiogenesis by promoting cross-talk between AMP-activated protein kinase and Akt signaling in endothelial cells.	The Journal of biological chemistry	2004	194
14752031	9370	Kobayashi H	Selective suppression of endothelial cell apoptosis by the high molecular weight form of adiponectin.	Circulation research	2004	125
15181024	9370	Goldstein BJ	Adiponectin: A novel adipokine linking adipocytes and vascular function.	The Journal of clinical endocrinology and metabolism	2004	105
16651465	9370	Ohashi K	Adiponectin replenishment ameliorates obesity-related hypertension.	Hypertension	2006	95
17227956	9370	Potenza MA	EGCG, a green tea polyphenol, improves endothelial function and insulin sensitivity, reduces blood pressure, and protects against myocardial I/R injury in SHR.	American journal of physiology. Endocrinology and metabolism	2007	59
17374708	9370	Anderson PD	Innate immunity modulates adipokines in humans.	The Journal of clinical endocrinology and metabolism	2007	56
17540190	9370	Sacks HS	Human epicardial adipose tissue: a review.	American heart journal	2007	141
23781214	9370	Kwon H	Adipokines mediate inflammation and insulin resistance.	Frontiers in endocrinology	2013	62
25110685	9370	Nigro E	New insight into adiponectin role in obesity and obesity-related diseases.	BioMed research international	2014	34
11248683	10021	Moosmang S	Cellular expression and functional characterization of four hyperpolarization-activated pacemaker channels in cardiac and neuronal tissues.	European journal of biochemistry	2001	91
14657344	10021	Stieber J	The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart.	Proceedings of the National Academy of Sciences of the United States of America	2003	89
17478540	10021	Gaborit N	Regional and tissue specific transcript signatures of ion channel genes in the non-diseased human heart.	The Journal of physiology	2007	111
19555650	10021	Zolles G	Association with the auxiliary subunit PEX5R/Trip8b controls responsiveness of HCN channels to cAMP and adrenergic stimulation.	Neuron	2009	48
23743334	10021	Liang X	HCN4 dynamically marks the first heart field and conduction system precursors.	Circulation research	2013	33
23974038	10021	Später D	A HCN4+ cardiomyogenic progenitor derived from the first heart field and human pluripotent stem cells.	Nature cell biology	2013	37
8181668	10242	Albelda SM	Adhesion molecules and inflammatory injury.	FASEB journal 	1994	131
8381058	10242	Ungerer M	Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.	Circulation	1993	143
9918525	10242	Bowling N	Increased protein kinase C activity and expression of Ca2+-sensitive isoforms in the failing human heart.	Circulation	1999	99
12176889	10365	Dekker RJ	Prolonged fluid shear stress induces a distinct set of endothelial cell genes, most specifically lung Krüppel-like factor (KLF2).	Blood	2002	147
15136591	10365	SenBanerjee S	KLF2 Is a novel transcriptional regulator of endothelial proinflammatory activation.	The Journal of experimental medicine	2004	159
16049344	10365	Dekker RJ	Endothelial KLF2 links local arterial shear stress levels to the expression of vascular tone-regulating genes.	The American journal of pathology	2005	68
16341264	10365	Parmar KM	Integration of flow-dependent endothelial phenotypes by Kruppel-like factor 2.	The Journal of clinical investigation	2006	166
16455954	10365	Dekker RJ	KLF2 provokes a gene expression pattern that establishes functional quiescent differentiation of the endothelium.	Blood	2006	84
17913848	10365	Hastings NE	Atherosclerosis-prone hemodynamics differentially regulates endothelial and smooth muscle cell phenotypes and promotes pro-inflammatory priming.	American journal of physiology. Cell physiology	2007	63
19968965	10365	Villarreal G Jr	Defining the regulation of KLF4 expression and its downstream transcriptional targets in vascular endothelial cells.	Biochemical and biophysical research communications	2010	50
21768538	10365	Wu W	Flow-Dependent Regulation of Kruppel-Like Factor 2 Is Mediated by MicroRNA-92a.	Circulation	2011	73
22267480	10365	Fang Y	Site-specific microRNA-92a regulation of Kruppel-like factors 4 and 2 in atherosusceptible endothelium.	Arteriosclerosis, thrombosis, and vascular biology	2012	69
27027284	10365	Zhou Z	Cerebral cavernous malformations arise from endothelial gain of MEKK3-KLF2/4 signalling.	Nature	2016	13
12563316	10544	Cheng T	Activated protein C blocks p53-mediated apoptosis in ischemic human brain endothelium and is neuroprotective.	Nature medicine	2003	145
12970121	10544	Esmon CT	The protein C pathway.	Chest	2003	112
15710622	10544	Finigan JH	Activated protein C mediates novel lung endothelial barrier enhancement: role of sphingosine 1-phosphate receptor transactivation.	The Journal of biological chemistry	2005	131
23741007	10544	Moxon CA	Loss of endothelial protein C receptors links coagulation and inflammation to parasite sequestration in cerebral malaria in African children.	Blood	2013	64
17916362	23411	Ota H	Sirt1 modulates premature senescence-like phenotype in human endothelial cells.	Journal of molecular and cellular cardiology	2007	95
18641460	23411	Potente M	Emerging roles of SIRT1 in vascular endothelial homeostasis.	Cell cycle	2008	53
19286634	23411	Orimo M	Protective role of SIRT1 in diabetic vascular dysfunction.	Arteriosclerosis, thrombosis, and vascular biology	2009	47
20089851	23411	Tanno M	Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure.	The Journal of biological chemistry	2010	79
20627091	23411	Ito T	MicroRNA-34a regulation of endothelial senescence.	Biochemical and biophysical research communications	2010	69
21746786	23411	Donato AJ	SIRT-1 and vascular endothelial dysfunction with ageing in mice and humans.	The Journal of physiology	2011	40
21778425	23411	Zhou S	Repression of P66Shc expression by SIRT1 contributes to the prevention of hyperglycemia-induced endothelial dysfunction.	Circulation research	2011	44
22455351	23411	Chen AF	Free radical biology of the cardiovascular system.	Clinical science	2012	30
23878368	23411	Gliemann L	Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men.	The Journal of physiology	2013	40
25538153	23411	Planavila A	Fibroblast growth factor 21 protects the heart from oxidative stress.	Cardiovascular research	2015	21
25815111	23411	Maiese K	SIRT1 and stem cells: In the forefront with cardiovascular disease, neurodegeneration and cancer.	World journal of stem cells	2015	18
12186805	23576	Lin KY	Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.	Circulation	2002	104
17273169	23576	Leiper J	Disruption of methylarginine metabolism impairs vascular homeostasis.	Nature medicine	2007	95
10598133	51327	Ignarro LJ	Nitric oxide as a signaling molecule in the vascular system: an overview.	Journal of cardiovascular pharmacology	1999	101
12512688	51327	Ignarro LJ	Nitric oxide as a unique signaling molecule in the vascular system: a historical overview.	Journal of physiology and pharmacology 	2002	142
21841020	79784	Weiss EP	Caloric restriction: powerful protection for the aging heart and vasculature.	American journal of physiology. Heart and circulatory physiology	2011	39
23798412	79784	Sommese RF	Molecular consequences of the R453C hypertrophic cardiomyopathy mutation on human β-cardiac myosin motor function.	Proceedings of the National Academy of Sciences of the United States of America	2013	37
25552695	79784	Moss RL	Cardiac MyBP-C regulates the rate and force of contraction in mammalian myocardium.	Circulation research	2015	26
9836530	100506658	Antonetti DA	Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells. Penn State Retina Research Group.	Diabetes	1998	115
19470647	100506658	Siu ER	Focal adhesion kinase is a blood-testis barrier regulator.	Proceedings of the National Academy of Sciences of the United States of America	2009	52
21294650	100506658	Carrano A	Amyloid Beta induces oxidative stress-mediated blood-brain barrier changes in capillary amyloid angiopathy.	Antioxidants and redox signaling	2011	45
21909359	100506658	Biron KE	Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease.	PloS one	2011	49
22197032	100506658	Xu R	HIV-1 Tat protein increases the permeability of brain endothelial cells by both inhibiting occludin expression and cleaving occludin via matrix metalloproteinase-9.	Brain research	2012	37
